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The development of a multi-cellular organism from a single-celled fertilized egg is an 
autonomous process, requiring no instructions from the environment in which it develops. 
So the program specifying the instructions for the development of an organism lies hidden 
in the genome. In any cell, it is the specific combination of transcription factors present; in 
the context of its environment that defines the identity of the cell. It is these 2 components, 
the transcription factors and the cis-regulatory elements that read the regulatory state of a 
cell that form the Gene Regulatory Networks (GRNs) which control development.  
Studying gene regulatory networks involves the identification of the transcription factors 
expressed and the cis-regulatory elements that are active in a particular cell lineage. It also 
involves studying gene interactions at the transcriptional regulatory level and at protein 
interaction level. GRNs for certain lineage specification have been mapped in detail in 
invertebrate systems like sea urchin and in certain in vitro model systems for vertebrates. 
Studying GRNs in vertebrate development poses various challenges, arising from the 
complexity of the genome and the body plans of vertebrates. This necessitates the 
development of novel approaches to study GRNs in development. Developments in 
transgenic methods, genomic and proteomic technologies have opened new vistas for 
exploring gene regulatory networks in detail. Whole genome gene expression profiling using 
microarrays and mass spectrometry based methods for identification of protein-protein 
interaction and massively parallel sequencing methods for mapping transcription factor 
binding sites are some of the new developments that enable us to dissect gene regulatory 
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networks. My projects involve developing methods and strategies to study GRNs in 
vertebrate development. 
One of the projects involves developing technology to isolate cells of a specific lineage from 
a mixture of other cells in the developing mouse embryo and study the gene regulatory 
pathway involved in the specification process. In a collaborative effort with in the lab, we 
have successfully generated Sox9+/+, Sox9+/- and Sox9 -/- chimeras expressing EGFP in Sox9 
expressing cells in the developing mouse embryo. For studying the chondrogenic 
specification pathway, for which Sox9 is a master regulator, we have obtained whole 
genome gene expression data from sorted EGFP+ cells of all the three genotypes at E13.5 
and E12.5 stages. Several differentially expressed genes between the three genotypes and 
the two time points have been identified. This includes well known targets of Sox9 and 
other known factors involved in osteo-chondro lineage development. Further studies are 
required to dissect out the GRN involved in this developmental pathway.  
My second project aims to develop and refine a method to identify long and short range cis-
regulatory elements for developmental genes. These elements are often hidden in the vast 
deserts of non-coding DNA in vertebrate genomes. Computationally predicted conserved 
non-coding elements are assayed in vivo in developing zebrafish embryos for regulatory 
activity. A strong forebrain enhancer for the dlx5a/dlx6a bi-gene cluster in zebrafish has 
been identified. Enhancers driving the expression of this gene pair in other domains are yet 
to be identified. 
 And finally, my other project involves developing a method for generating ES cell lines 
expressing epitope tagged transcription factors for mapping protein-protein interaction 
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networks involved in pluripotency in mouse ES cells. Oct4-2xFlag-TEV-BAP expressing lines 




A note on my contributions 
As the first two projects described in the thesis are multi-authored projects, I’ve described 
my contribution to the specific steps in each of the projects. 
1) Chapter 2: Novel approaches to study cell type specification  
 
This project was started by Dr. Yap Sook Peng. All the three targeting constructs 
were made by her and the ES cell screening for the required genome modification 
was also done by her. Microinjection and most of the mouse work was done by 
Hsiao Yun and Dr. Petra. They generated the chimeras and dissected out the 
embryos.  
 
Section 2.2: In the preliminary technology testing section described in chapter 2, my 
contribution begins with preparing embryos for FACS. The sorting was done at the 
Biopolis Shared Facility. RNA extraction, quality checking, target preparation, 
microarray experiment and the preliminary data analysis described in this section 
were done by me.  In the method and results section, I’ve only explained those 
experiments done by me.  
 
Section 2.3: As mentioned in the thesis, for the main dataset, RNA extraction, target 
preparation and the microarray experiment was done by Dr. Yap Sook Peng.  For this 
main dataset, my contribution begins with the collection of raw microarray data. In 
this section, I’ve only explained the data analysis part of the experiment done by me.  
 
2) Chapter 3: Identification of enhancers for the Dlx5/Dlx6 bi-gene cluster 
 
This project was started by Dr. Selvi. The construction of the basal reporter vector 
and the cloning of the intergenic element, CNE2, CNE3 were done by her. The rest of 
the steps described in this section from setting up mating of zebrafish, preparation 
of constructs for microinjection, microinjection of zebrafish embryos, assaying for 






3) Chapter 4: Epitope tagging of Oct4 for mapping pluripotency network 
 





GRN  -  Gene Regulatory Network 
BAC  -   Bacterial Artificial Chromosome 
CNE  -   Conserved Non-coding Element 
EGFP  -  Enhanced Green Fluorescent Protein 
ES cells -  Embryonic Stem Cells 
FACS  -   Fluorescence Activated Cell Sorting 
FCS  -   Foetal Calf Serum 
GO  -   Gene Ontology 
AER   -  Apical Ectodermal Ridge 
PCR  -   Polymerase Chain Reaction 
UTR  -  Untranslated region 
LC  -   Liquid Chromatography 
MS  -   Mass Spectrometry 
TAP  -   Tandem Affinity Purification 
TEV  -   Tobacco Etch Virus 
BAP  -   Biotin Acceptor Peptide 
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DNA  -   Deoxyribo Nucleic Acid 
RNA  -   Ribo Nucleic Acid 
SOX  -  Sry-related HMG box transcription factors 
DLX  -  Distal-less related homeo-box containing transcription factors 
OCT4  -  Octamer-4; Synonym of POU5F1 
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GENE REGULATORY NETWORKS (GRNs) IN DEVELOPMENT 
The development of a multi-cellular animal from a single cell involves a myriad of 
processes ranging from cell-division, differentiation to cells that perform specific 
functions, and migration of these cells to distinct domains in the developing embryo.  
“The mechanism of development has many layers. At the outside development is 
mediated by the spatial and temporal regulation of expression of thousands and 
thousands of genes that encodes the diverse proteins of the organism. Deeper in is a 
dynamic progression of regulatory state, defined by the presence and activity in the 
cell nuclei of particular sets of DNA recognizing regulatory proteins (transcription 
factors), which determines gene expression. At the core is the genomic apparatus 
that encodes the interpretation of these regulatory states. Physically the core 
apparatus consists of the sum of modular DNA sequence elements that interact with 
transcription factors. The regulatory sequences read the information conveyed by the 
regulatory state of the cell, process that information and enable it to be transduced 
into instructions that can be utilized by the biochemical machines for expressing 
genes that all cells possess.”  
              – Eric H. Davidson – The Regulatory Genome: Gene Regulatory Networks in                              




The whole process of development of an embryo can be viewed as dynamic 
progression through a series of regulatory states. Wherein, the regulatory state is 
defined as the total sum of all the transcription factors present in the nucleus of a 
cell. The fertilized egg and its descendants share the same genome. The regulatory 
state in a cell along with other signaling cues from its environment are read by the 
genome’s processing units referred to as cis-regulatory modules (Smadar et al., 
2007; Davidson E.H. 2006)  
Cis-regulatory elements act as processors for regulatory inputs and process the 
various signals to generate an output in the form of an expression level of a gene at a 
particular time point. Through transcription factor-specific binding sites, it brings 
together proteins of specific regulatory properties into close proximity, and the 
complex regulates the rate at which specific genes are expressed (Davidson 
E.H.2006).   
These inter-regulating genes form the gene regulatory networks that control 
development. There are some general features of Gene Regulatory Networks: 1) It is 
the specific combination of transcription factors present in the nucleus at a 
particular state of the cell, along with the signaling cues that arise as a result of its 
spatial domain in the embryo, that controls the activation or repression of cis-
regulatory elements that drives/silences the expression of the regulatory genes; 2) 
The networks are modular and consisting of several sub-circuits, with each sub-
circuit performing a specific developmental task; 3) And the sub-circuits are 
generally composed of functional units: regulatory states turn on by specific 
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signaling, specification establishment and persistence by positive feed-back loops 











Gene regulatory networks involved in various specification pathways have been 
mapped. But the list mainly includes invertebrate systems and vertebrate systems 
 Fig 1.1: Genomic Regulatory system (Figure taken from Smadar et al., 2007) 
 a) An individual cis-regulatory element – non-random tight cluster of transcription 
factor binding sites. 
 b) A regulatory gene – The exons of the gene are shown as green boxes and the cis-
regulatory elements are shown as pink boxes. This gene has 6 cis-regulatory 
modules, each of which or a subset of these direct the lineage specific expression of 
the gene at different time points. 
c) Developmental Gene Regulatory Network:  Transient spatial signaling cues are 
conveyed to the transcriptional machinery in the nucleus by intra-cellular signaling 
pathways. These cues along with the transcription factors already present in the 
nucleus drive the expression of regulatory genes, which regulates the expression of 
a subset of its target genes (in the context of the present regulatory state). These 
factors in turn may establish feed-forward loops to establish a stable regulatory 




for which in vitro models are available. Table 1.1 lists some of the systems and the 
domain/specification pathway studied.   
 
 
Organism  Domain  specification  References  
Sea urchin  Endomesoderm  Davidson EH et 
al.,2006  
Starfish  Endoderm Hinman EF et al.,2003  
Mouse  Pancreatic β-cells  Davidson EH et 
al.,2006;  
Mouse  Hematopoietic stem 
cells  
Servitja JM et al.,2004  
Mammals  B-cell specification  Swiers G et al.,2006  
Mammals  T-cell specification  Singh H et al.,2006; 
Anderson MK et 
al.,2002  
Vertebrates  Heart field 
specification  
Davidson EH. 2006  
Frog  Mesoderm  Koide T et al.,2005  
Ascidian  Notochord  Corbo JC et al.,1997  
Drosophila  Heart field  Davidson EH et 
al.,2006 
Drosophila  Dorso-ventral axis  Levine M et al., 2005  
Nematode  Vulva  Inoue T et al., 2005  
Nematode  C-cell lineage  Baugh LR et al.,2005  
 
 
Table 1.1: Some of the domains/specification pathways for which GRNs have 




Construction of gene regulatory network maps involves the analysis of large 
amounts of experimental data such as gene expression data, data from gene 
perturbation studies, protein-protein interaction data and direct assays of cis-
regulatory regions using transgenic methods. The following diagram shows the 
endomesoderm specification pathway in sea urchin. Arriving at such a detailed cis-
regulatory logic diagram for all the genes involved in a pathway takes tremendous 





Fig 1.2: Endomesoderm specification pathway to 30hr (just before gastrulation) 
in sea urchin. Gene regulatory network map for the specification of several 
endomesodermal lineages till gastrulation. Progression through time is 




Studying Gene Regulatory networks (GRNs) in a particular domain/lineage 
specification involves the identification of the transcription factors expressed and 
the cis-regulatory elements that are active in a particular state of the cell, as it 
progresses toward a particular specification state.  
Advances in genomic and proteomic technologies such as whole genome 
microarrays and mass spectrometry based proteomics for the identification of 
protein-protein interaction and the availability of whole genome sequences for many 
species across different phylogenies allow us to explore GRNs for domain 
specification in a variety of organisms. 
This chapter has introduced briefly the framework in which most modern studies in 
developmental biology are done.  
All my projects involve developing and testing methods to study various aspects of 
gene regulatory networks in vertebrate development. Chapter 2 discusses the 
project that aims to develop novel approaches to study cell type specification. 
Chapter 3 discusses the project that aims to study cis-regulatory elements for 
developmental genes. Chapter 4 discusses the project which aims to develop a high-
throughput method for efficient tagging of transcription factors in mouse ES cells for 
purification of protein complexes for mass spectrometry based identification of 
protein interaction network. Each of the chapters contains introduction, methods, 








Novel approaches to study cell type specification in vertebrates 
 
“Specification is the process by which cells acquire their identities that they and their 
progeny will adopt. On the mechanism level, that means that the process by which 
the cells acquire the regulatory state that defines their identities.  An initial set of 
transcription factors together with the signaling cues from the neighboring cells 
activate a number of cis-regulatory modules. The active modules turn on the 
expression of regulatory genes that construct the next regulatory state of the cell 




Exploring the Gene Regulatory Networks (GRN) in a specification process is studying 
the process at a fundamental level. For exploring GRNs in a particular cell type 
specification process, the complete set of transcription factors expressed in a 
particular cell type during the differentiation process must be known.  
The regulatory interactions can be deciphered by perturbing one factor and looking 
at its effect on the expression levels of the other factors. By such studies it is possible 
to identify the genes involved in a particular pathway and their interactions. 
 For whole genome expression analysis, the particular cell type under study must be 
separated from the other types of cells present in the embryo. One of the difficulties 
“Specification state: a regulatory state that is cell-type specific so it defines 
the cell identity and the differentiation genes that it expresses.”(Davidson 





in studying cell type specification process in vertebrates is the sheer complexity of 
the system, with a particular cell type present in different domains in the developing 
embryo, comprising only a very small fraction of the whole embryo. As the 
specification process is highly dependent on the niche in which the cells are present, 
in most cases it is almost impossible to model the specification process in vitro. It is 
also complicated by the huge size of vertebrate genomes in which the functional 
elements comprise a very small fraction. 
These challenges necessitate the development of novel approaches to study GRNs in 
vertebrate development. One of the popular ideas is to combine transgenic 
approaches with genomic technologies to study GRNs in vertebrate development. 
Developments in transgenic methods, cell sorting techniques and whole genome 
gene expression analysis allow us to tackle this problem. Other methods include 
using in vitro cell culture models to study development. Several studies have 
indicated huge differences in gene expression profiles of primary cultures and cell 
lines. Some studies have reported there is only around 60% overlap in transcription 
factor binding data from primary cultures and cell lines (Duncan et al., 2007). These 
studies stress the importance of using in vivo systems to address problems in 
development.  Figure 2.1 shows an overview of the approach used to study cell type 











Here the important steps in the process are described. 
1) One of the alleles (+/-) or both the alleles (-/-) of a cell lineage specific marker 
is  knocked out with EGFP coding sequence in a BAC , containing the gene of 
interest, to generate the targeting construct in a bacterial system. 2) Then 
the targeting construct is electroporated into ES cells and the ES cells are 
then screened for the specific genome modification. 3) The ES cells that are 
positive for the modification are then microinjected into blastocysts. 4) Then 
the chimeras generated are checked for germ-line transmission. The mice 
Fig 2.1: Schematic diagram of the technology we are developing for global 
gene expression profiling of specific population of cells. (Diagram obtained 





that show germ-line transmission are mated to generate heterozygotes. The 
embryos from these matings are screened for EGFP expression in specific 
tissues at specific developmental stages depending on the time of expression 
of the cell-lineage specific gene. 5) Then the EGFP+ embryos are made into 
single-cell suspension. 6)  In the next step, the EGFP+ cells (cells of the 
specific lineage that we are interested in) are sorted from the rest of the cells 
in the embryo by Fluorescence Activated Cell Sorting (FACS). Once the cells 
are sorted, total RNA can be extracted from the cells and used for target 
preparation for microarray gene expression analysis, which will give us a 
glimpse of the genes expressed in the particular cell type. By comparing gene 
expression profiles of the +/+, +/- and -/- cell populations, genes whose 
expression levels are affected by the perturbation of the transcription factor 
that we modified can be identified. These genes are likely to be the 
downstream targets of gene X.   
             Technical challenges:    
1) The first is the generation of chimeras that show germ-line transmission. 
Injection of ES cells (selected for the specific genome modification) into 
blastocyst stage embryos often results in a very low degree of chimerism, as 
the injected ES cells have to compete with those already present in the 
blastocysts. Some new methods have been developed to overcome this. For 
example, Regeneron Pharmaceuticals Inc. has come up with a method for the 
laser-assisted injection of mouse ES cells into 8-cell staged embryos that 





ES cell derived mice show 100% germ line transmission (Valenzuela et al., 
2003). 
2) The second is the optimization of the sorting process. As a cell’s regulatory 
state is highly dependent on its niche in the embryo, the cell’s gene 
expression state may change and the cells may die when the embryo is 
disintegrated into single cells. One way to prevent this is to extract the total 
RNA from the specific cells of interest as soon as it is separated. But the FACS 
process prohibits this. The FACS machine sorts at a speed 107 cells/hour. So it 
takes at least 2hours from the time of disintegration of the embryo into 
single cells to extract total RNA from the cell population of interest for a 13.5 
day mouse embryo. The other factors that are to be considered are the 
accuracy and sensitivity of the sorting process. Accuracy here refers to the % 
fraction of EGFP + cells in the positive fraction and the % loss of EGFP+ cells in 
the negative fraction. Sensitivity refers to the level of GFP expression that can 
be detected by the FACS machine (High sensitivity means that it can detect 
low levels of EGFP expression).   
3) The third is the amount of RNA that can be extracted from the sorted lineage 
specific cells, which depends on a number of factors: i) the number of cells, of 
the lineage under study, present in the embryo at a particular stage of 
development; ii) the efficiency of the sorting process; iii) the efficiency of the 
RNA extraction method. The amount of RNA that is required for downstream 
applications depends on the platform that we are using. For example, the 





material for probe preparation, whereas the Affymetrix platform requires at 
least 1.5µg as starting material for probe preparation.  
For many cell lineages, the amount of RNA that can be extracted is in pico 
grams. Thus it necessitates the amplification of extracted RNA for many 
downstream purposes.  
Essentially, there are two amplification methods: 1) Exponential method 
based on PCR based protocols and 2) linear amplification methods based on 
T7 promoter based in vitro transcription (Kurimoto et al., 2006; Tietjen et al., 
2003).  
Illumina technology for gene expression profiling: Illumina has created a 
microarray technology with randomly arranged beads. A specific oligonucleotide is 
assigned to each bead type and is replicated 30 times on average in an array. Each 
bead is around 3µm in diameter and around 700,000 copies of an oligonucleotide 
are covalently linked to each bead. And the bead types are arranged randomly in an 
array. A series of decoding hybridizations is done to identify the location of each 
bead type. Each bead type is defined by a unique DNA sequence that is recognized 
by a complementary decoder (Dunning, M et al., 2007). This decoding process is 
highly effective and has an error rate less than 10-4 (Gunderson et al., 2004). A 
beadchip consists of a rectangular series of arrays each having around 24,000 bead 
types. For example, the mouse ref-6 chip consists of six pairs of arrays. Compared 
with other platforms, Illumina beadchips require only 50ng of total RNA from 
samples. This is then amplified in the labeling step by in vitro transcription based 





hybridization (refer appendix 2.11 and 2.12 for detailed protocol for labeling and 
hybridization). 
Gene regulatory networks: Once high quality gene expression data from the wild 
type and knockout samples at different time points are obtained, it is important to 
reconstruct the gene regulatory network. Several mathematical formalisms for 
modeling gene regulatory networks from expression data are available. These 
include directed graphs (DG), Bayesian networks (BN), dynamic Bayesian networks 
(DBN), Boolean networks, non-linear differential equations, partial differential 
equations, network component analysis, stochastic master equations are some of 
these. For a detailed overview of these methods refer to (Hidde De Jong.2002).  
2.1 TECHNOLOGY DEVELOMENT: For developing this technology and at the same 
time studying the chondro-osteo lineage specification in mouse, we picked Sox9, a 
master regulator of chondrogenesis. Its expression starts at 9dpc and extends till 
14dpc. Heterozygous mutants die after birth and phenocopy the skeletal anomalies 
of campomelic dysplasia. Homozygous null embryos die at 11.5dpc (Akiyama et al., 
2005; Akiyama et al., 2002; Wright et al., 1995).  As the loss of even one allele leads 
to changes in the phenotype, it is likely that the expression levels of Sox9 affects its 
target genes. By comparing the expression profiles of Sox9 (+/+), (+/-), and (-/-) cell 
populations, we will be able to dissect the regulatory pathway involved in the 
chondro-osteo lineage specification. 
The process of endo-chondral ossification starts with mesenchymal stem cells 
acquiring chondrogenic potency. The mesenchymal stem cells guided by various 





cells go through a progression of stages characterized by proliferation and 





















Fig 2.2: WMISH for Sox9 
(E13.5), showing the 
expression of Sox9 in the 
digits, nasal cartilage. 
(Figure obtained from 




Image adapted from 
(Edwina Wright et.al, 1995) 
Fig 2.3: Diagram of the transcription factors involved in the 
chondrocytes/osteoblasts specification pathway. (Diagram obtained from 





Sox9 is a Sry-related HMG box transcription factor that is expressed strongly in all 
chondro-progenitors and in all differentiated chondrocytes, but not in hypertrophic 
chondrocytes. Inactivation of Sox9 during or after mesenchymal condensations 
results in a very severe chondrodysplasia, which is characterized by an almost 
complete absence of cartilage in the endochondral skeleton. Sox9 has been shown to 
be required at sequential steps in chondrogenesis before and after mesenchymal 
condensations (Akiyama et al., 2005; Wright et al., 1995; Akiyama et al., 2002). 
Other transcription factors like Sox5 and Sox6 are also important at the various 
stages of the chondrogenic specification pathway and together with Sox9 have been 
shown to regulate chondrocytes specific genes like Col2a1, Aggrecan, and Col11a2 ( 
Akiyama et al., 2002; Ng et al., 1997). 
To dissect out the gene regulatory network involved in chondrocyte specification, 
Sox9 and other important regulators involved can be knocked out or knocked in with 
EGFP and the chondrogenic cells sorted for gene expression profiling and ChIP-seq 
analysis. From these data and analysis of cis-regulatory elements by transgenic 
assays, the gene regulatory network can be reconstructed. For the detailed protocol 
for reconstructing GRNs, refer to (Stefan C Materna & Paola Oliveri.2008).  
The various targeting constructs used for generating chimeras are given in Figure 2.4. 
The targeting constructs were generated using the Red/ET method (Zhang Y et al., 
1998, Zhang Y et al., 2000) 









The targeting constructs were electroporated into V6.4 ES cells and following 14 
days of selection were picked and screened for the specific genome modification 
using southern blotting. For generating Sox9+/+ ES clones, targeting construct (i) was 
used. Sox9+/- ES clones were generated using targeting construct (ii) and Sox9-/- 
clones were generated using both the (ii) and (iii) constructs. ES (v6.4) clones that 
showed positive for the desired genome modification were microinjected into 
blastocysts derived from C57Bl6 strain mice.  
 
Fig 2.4: Targeting Constructs for generating Sox9 +/+, +/-, -/- mice (Diagram 





























Wt Sox9 +/+ 
Sox9+/- 
(EGFP+) 
Fig 2.5: E13.5 Sox9+/- (EGFP+) & Wt 
Sox9+/+ under white light and 
fluorescence microscope (images 




Fig 2.6: Sox9+/- chimeric embryo generated using veloci-







2.2 Preliminary testing of the technology 
For preliminary testing of the sorting process and gene expression analysis and to 
optimize the individual steps, differential gene expression profiling of the EGFP+ and 
EGFP- cell populations in the Sox9+/- chimeric embryos was done. The following 
section describes the methods used and the results that we have obtained.  
Methods:  
FACS:  The Sox9+/- chimeric embryos were screened for EGFP expression using a Leica 
fluorescence microscope. Those embryos that showed positive EGFP expression 
were made into single cell suspension using an enzyme cocktail consisting of trypsin, 
dispase, and collagenase. The single cell suspension was then sorted into EGFP+ and 
EGFP- fractions using BD FACS aria cell sorter. The sorted cells were collected in 
Leibovitz medium with 5%FCS.  
RNA extraction and analysis: Total RNA was extracted from the sorted cells using 
Qiagen RNeasy mini kit. The detailed protocol for RNA extraction can be found in 
appendix 2.1. The extracted RNA was quantified with the nanodrop and analyzed for 
its integrity with the RNA6000Pico assay chip in the Agilent Bio-analyzer system. 
Target preparation: Total RNA extracted from the EGFP+ and EGFP- fractions from 
two Sox9+/- chimeric embryos was pooled together. 50 ng of the total RNA from the 
pooled fraction was amplified and labeled for array analysis using the Illumina Total 
Prep RNA Amplification Kit. The detailed protocol for amplification and labeling of 





 Microarray: For global gene expression profiling, we used the Illumina mouse Ref6 
chip. Both the EGFP + and EGFP - fractions were hybridized in technical duplicates. 
The hybridization protocol is given in appendix 2.11. And the data obtained was 
analyzed using the Illumina Bead Studio software.  
2.2.1 Results and Discussion:  
FACS: Representative FACS results from one of the E13.5 Sox9+/-chimeric embryos 
used for preliminary studies are shown below. Figure 2.7 and 2.8 shows the pre-sort 
analysis of one E13.5 Sox9+/-chimeric embryo and the post-sort analysis of its EGFP 
fraction respectively. 
  
                                                                                           
 
 
Fig 2.7: Presort analysis: 1.1% of the total no. of detected 
events is EGFP+. Approximately, 1.1% of the cells in the 












RNA extraction and Analysis:  
A representative electropherogram of the total RNA extracted from the EGFP+ cell 
fraction is given below. Total RNA was extracted from the sorted populations using 
the Qiagen RNeasy mini kit. The total yield of RNA extracted from the two samples 
used for preliminary analysis and the sample integrity are shown below:   
Sample No. of  events sorted 
into the EGFP+ fraction: 
Total yield of RNA (ng) 
Sample 1 43,000 27.15 
Sample 2 24,000 39.3 
 
Fig 2.8: Post sort analysis of the EGFP+ fraction: 93.5% of the P2 
population is EGFP+. Only 6.5% is EGFP-. Even though the purity of 
the fraction is good, only 13.5% of the events fall within the scatter 
gate, which means that 87.5% of the sorted EGFP+ fraction is found 












All the samples in the electropherogram above are total RNA preparations from 
EGFP+ fractions of E13.5 Sox9+/- chimeric embryos. Only samples 1 and 2 in lanes 6 
and 9 show sample integrity and were used for target preparation. 
Differential expression analysis of the EGFP+ and EGFP- fractions in the chimeric 
embryos has identified several genes that are positively enriched in the EGFP+ 
fractions. A list of genes that are clustered with Sox9 and known to be involved in the 
chondrogenic pathway is given below. A few markers with unknown function were 
also found to be clustered with Sox9. These results from the preliminary testing of 
the process were highly encouraging and helped us proceed to the next stage, where 
we compared Sox9+/+, +/-, -/-  EGFP+ cell populations at E12.5 and E13.5 to decipher 
the GRNs involved in the chondrogenic specification pathway.                                                            
   Sample 1  Sample 2 
 Fig 2.9: Electropherogram of the Total RNA extracted from EGFP+ fractions: Only 
samples 1&2 in lanes 6 and 9 show no degradation, indicated here by the 
presence of 2 discrete bands corresponding to 28s and 18s rRNA and without 














   Genes clustered with   
Sox9  
Genes that 
are known to 








Pax1  Pax1  Zfp277  
Pax9  Sox5  Zcchc5  
Bapx1  Sox9   
Sox5  Col2A1   
Sox6  Col8A2   
Sox9  Col9A1   
Runx2  Col9A2   
Runx3  Col27A1   
Col2A1  Aggrecan1   
Col9A1  Osteomodulin   
Col9A2  Osteoglycin   
Col9A3  Osterix   
Col11A2  HoxA7   
Aggrecan  BmpR1b   
Osterix Pthr1   
HoxA7   
 
Table 2.1: List of genes that are 
enriched in the EGFP+ fraction:  
Genes that are known to be 
involved in the chondrogenic 
pathway and genes that are 






2.3 Microarray data analysis of the main dataset 
To study the gene regulatory networks involved in the osteo-chondrogenic 
specification pathway, microarray gene expression data from EGFP+ cells sorted 
from mouse embryos of Sox9+/+, Sox9+/-, and Sox9-/- genotypes at E13.5 and E12.5 
stages was generated using Illumina mouse Ref-6 beadchips. The data were 
generated by Dr. Yap Sook Peng. This section discusses the methods used for 
microarray data analysis alongside a brief introduction to the methods. The results 
obtained from the analysis are also discussed. 
2.3.1 Differential Expression Analysis  
The  data analysis was done using bioconductor packages in the environment of R. 
Bioconductor is a widely used open source software for the analysis of high-
throughput genomic experiments such as microarray. It is based in the open source 
statistical computing environment of R. A variety of packages are available for the 
analysis of data from specific platforms (Gentleman, R.C. et al., 2004).  
Beadarray is an R/Bioconductor package designed specifically for the analysis of 
genomic experiments done using Illumina platform (Dunning et al., 2006; Dunning et 
al., 2007). Raw data or summarized data exported from Illumina’s Beadstudio 
software can be read into convenient R classes for further analysis with other 
Bioconductor packages.  
The beadarray package can be used to read in the background corrected bead 
summary data into expression set Illumina object. Expression set Illumina is an 
extension of the Expression Set class object used as a container for data from high-





the use of simple commands and subsetting. The sample information and sample 
group information for the arrays can be obtained using pData function. 
Filtering and normalization can be done with the beadarray package. Differential 
expression analysis can be done using the limma package.  
Limma: Limma (Linear models for microarray analysis) is a package for differential 
expression analysis of microarray data. Limma uses linear models to analyze gene 
expression data. The expression data can be log-intensity values from single channel 
technologies such as Illumina beadchips. Empirical Bayes method can be used to 
borrow information across genes. The approach requires two matrices to be 
specified. The first is the design matrix which specifies the different RNA targets that 
were hybridized. The second is the contrast matrix, which allows the coefficients 
specified by the design matrix to be combined into contrasts of interest. The first 
step is to fit a linear model using lmFit function. Each row of the design matrix 
corresponds to an array and each column to a coefficient.  The second step is to use 
contrasts.fit function that allows the fitted coefficients to be compared in as many 
ways as wanted. And empirical Bayes method can be used to borrow information 
across genes and this is done using the function eBayes in limma package (Smyth 
G.K. 2005). 
Limma also provides functions topTable and decideTests that summarize the results 
of the linear model, perform hypothesis tests and adjusts the p-values for multiple 
testing. The basic statistic used for significance analysis is the moderated t-statistic. 
Here the standard errors are shrunk towards a common value, using a simple 





p-values can be adjusted for multiple testing. One of the most popular methods for 
p-value adjustment is the “fdr” method and is used to control the false discovery 
rate. B statistic is the log-odds ratio that the gene is differentially expressed. Given a 
B statistic of value “x”, the probability that the gene is differentially expressed is 
given by x/(1+x).  
Another useful statistic to come out of the eBayes function is the moderated F-
statistic. This combines the t-statistics for all the contrasts into an overall test of 
significance for that gene. A p-value is associated with the F-statistic like the usual t-
statistics.  
2.3.2 Sample information and Preprocessing 
The samples were assigned to the chips according to the principles of randomization. 
The schematic representation of the sample assignment to the chips is given in 
Figure 2.10. All the samples are in technical duplicates. There are three biological 
replicates for E13.5 Sox9+/+, Sox9+/- and E12.5 Sox9+/+ and Sox9+/- samples, as well as 
two biological replicates for the E13.5 Sox9-/- samples. Totally 28 samples were 
hybridized to 28 arrays in 5 chips. Figure 2.10 shows the schematics of sample 
assignment to the chips. 
The arrays were then scanned and image analyzed to produce files containing raw 
intensity values for each of the probes in every array. The raw data from the 
microarray experiments were read in to Beadstudio version 3.3. Beadstudio is 
Illumina’s proprietary software designed for the analysis of high-throughput genomic 
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Fig 2.10: Schematics of the sample 
assignment to the five illumina 
ref6 beadchips. Totally 28 arrays 
were hybridized. Each of the 
samples is in technical duplicates 





The default background correction method in Beadstudio was applied and bead 
summary data was exported. The sample probe file containing the Avg_signal, 
Bead_STDEV, No_Beads, and Detection scores for each of the arrays was exported 
from Beadstudio for further analysis with R/Bioconductor.  
Beadarray package was used to read the data in sample probe file into an expression 
set illumina object. Figure 2.11 shows the boxplot of the log transformed sample 
intensities revealing the distribution of intensity values for all the samples.  
The samples were normalized by the quantile normalization method. The idea of 
quantile normalization is to impose the same empirical distribution of intensities to 
each array. There is anecdotal evidence that this is the best method for normalizing 
illumina data.  Figure 2.12 shows the boxplot of log transformed sample intensities 
after quantile normalization.  
Around 46,632 probes are present in each of the arrays. Applying a filtering criterion 
of detection score above 0.99 and average signal above 100 across all the samples 
resulted in a set of 8758 probes. It is important to note that applying such a stringent 
cutoff may remove other interesting features that fail to show the cutoff scores in all 
the samples.  
Limma package was used for differential expression analysis. Here the first step is to 
specify the design and contrast matrices. In the following 2 sections, these matrices 
were defined according to the contrasts of interest.  The annotation information for 






      
 
 
Fig 2.11: Boxplot of log transformed sample intensities before normalization  





2.3.3. Differential Expression at E13.5 
 To identify the genes that are differentially expressed between the Sox9+/+,+/-,-/- 
genotypes, only the data from E13.5 stage were used as Sox9-/- data is not available 
for E12.5 stage. The design matrix and contrast matrix used for the analysis are given 
in Appendix 2.2 along with the code. Filtering for probes that have mapped Refseq id 
and mapped gene ontology (GO) terms gave a set of 3531 probes. Those GO terms 
with evidence code “IEA” and “ND” were not included in the analysis. This set of 
3531 probes was used for subsequent analysis. 
Of these, 2115 probes are differentially expressed. Figure 2.13 shows the overlap 
amongst these probes in the three contrasts. The first contrast is E13.5 Sox9+/+ vs 
Sox9-/- , the second contrast is E13.5 Sox9+/- vs Sox9-/- and the third contrast is E13.5 
Sox9+/- vs Sox9+/-. Applying a minimum fold change of 2, i.e. log2 (fold change) 
greater than or equal to 1 (up-regulated) or less than or equal to -1 (down-regulated) 
as threshold for differential expression and setting a cut-off of adjusted p-value less 
than or equal to 0.01 to this set gave a set of 510 probes for the first contrast, 485 
probes for the second contrast and 220 probes for the third contrast. 
Out of the 510 probes in contrast 1 and 485 probes in contrast 2, 255 probes are 
common between the 2 contrasts, i.e. 50% of the probes are similar in the two lists 
as it would be expected. There is not much overlap among the first 2 contrasts and 
the third one. Around 50% (100/221) of the probes present in the third contrast are 
also seen in the second and 33% (71/221) of the probes in the third are present in 






In this set, searching for probes whose GO terms contain the terms “skeletal”, 
“cartilage”, “transcription”, “osteo” and “chondro” gave an interesting set of genes 
that are known to be involved in the chondrogenic specification pathway. Even 
though the list is not similar among the three contrasts, there is some overlap.  
Table 2.2 A, B and C lists some genes from the list that are known to be involved in 
the osteo-chondrogenic pathway. The complete list of top 200 genes in each of the 
contrasts can be found in Appendix 2.4, 2.5 and 2.6. Due to space constraints only 
the gene symbol, logarithmic fold change and adjusted p-value are given. The list is 
sorted by adjusted p-value with top ranking genes on top of the table.  
13.5+/+     vs     
13.5+/-         
13.5+/-       
vs   13.5-/- 
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Fig 2.13: Venn diagram showing the overlap among probes for 






                                       E13.5  Sox9 +/+  vs  Sox9 -/-  




GO terms  
Col9a1  Cartilage development  
Gnas  Skeletal system development  
Col2a1  Cartilage development  
Ctgf  Cartilage condensation, Cell differentiation.  
Hoxa2  Osteoblast developement  
Sox5  Cartilage development  
Twsg1  Negative regulation of osteoblast differentiation  
Tgfb2  Skeletal system development  
Gna11  Skeletal system development  
Gnaq  Skeletal system development  
Osr2  Embryonic skeletal system morphogenesis  
Down regulated  
genes  
Hoxb4  Embryonic skeletal system morphogenesis, negative 
regulation of transcription.  
Hexa  Skeletal system development  
Pth1r  Skeletal system development, Chondrocyte 
differentiation  
Pax1  Skeletal system development  
Sp3  Ossification  
Hoxc9  Embryonic skeletal system morphogenesis  
Shox2  Chondrocyte development  
 
There are several other genes in these lists that may be of interest. Several 
transcription factors involved in cell differentiation pathways and developmental 
Table 2.2 A: List of up and down regulated genes in E13.5 Sox9 +/+ vs Sox9 -/- known to be 






processes, signaling molecules and extracellular matrix proteins are among the top 
ranked genes.  
It is important to remember that probes with no mapped Refseq id and GO terms 
were filtered out during the analysis. There may be several interesting features that 
have no annotation information as of now. The annotation packages used are given 
in Appendix 2.2. The latest version of the annotation packages was used. Hence the 
annotation information is up-to-date.  
Sox9 is conspicuous by its absence in the gene list. A search for the probe id 
corresponding to Sox9 in the Illumina annotation package gave an id that is not 
found even in the raw data set, which is very unfortunate. Hence, we are not able to 
ascertain the expression levels of Sox9 in the 3 different cell populations. 
Col2A1, Col9A1 and Sox5 among others are seen on top of the table in the up-
regulated genes list in both Sox9+/+ vs Sox9-/- and Sox9+/- vs Sox9-/- contrasts. Their 
absence in the third contrast Sox9+/+ vs Sox9+/- suggests that their level of expression 
is not that different in Sox9+/+ and Sox9+/- cell populations. These genes are well 
known targets of SOX9.  Their presence on top of the up-regulated genes list adds 
credibility to the data and analysis. Surprisingly, the genes Pax1, Pth1r are present in 
higher levels in Sox9-/- cell population than in Sox9+/+ and Sox9+/- cell populations at 
E13.5 stage. 
Several other regulators of cell differentiation and development like Hoxd4, Hoxd10, 





means that their expression levels in Sox9-/- cell population is higher compared to 
Sox9+/+ and Sox9+/-  . Some of these like Wnt9a and Shox2 are negative regulators.   
 
                   E13.5  Sox9 +/- vs  Sox9 -/-  




GO terms  
Col9a1  Cartilage development  
Gnas  Skeletal system development  
Col2a1  Cartilage development  
Ctgf  Cartilage condensation, Cell differentiation.  
Eya1 Embryonic skeletal system morphogenesis  
Sox5  Cartilage development  
Hmgb1 Positive regulation of mesenchymal cell proliferation 
Down regulated  
genes  
Hoxb4  Embryonic skeletal system morphogenesis, negative 
regulation of transcription.  Hoxd4  Embryonic skeletal system morphogenesis  
Acvr2b  Skeletal system development  
Pax1  Skeletal system development  
Sox4  Wnt receptor signaling pathway through beta-catenin  
Wnt9a  Negative regulation of chondrocyte differentiation, Embryonic 
skeletal system morphogenesis  
Hoxd10  Skeletal system development  
Hoxb5  Embryonic skeletal system morphogenesis  
Hoxd12  Skeletal system development  
Prrx1  Embryonic skeletal system morphogenesis  
Igfbp3  Osteoblast differentiation  
Shox2  Regulation of chondrocyte differentiation  
Hoxc9  Embryonic skeletal system morphogenesis  
Bmp4  Skeletal system development  
Wwtr1  Osteoblast differentiation  
Table 2.2 B: List of up and down regulated genes in E13.5 Sox9 +/- vs Sox9 -/- known to be 







                                         E13.5  Sox9 +/+  vs  Sox9 +/-  




GO terms  
Hoxd4 Embryonic skeletal system morphogenesis 
Acvr2b Skeletal system development  
Gnas Skeletal system development 
Msx1 Embryonic limb morphogenesis 
Igf1  Osteoblast differentiation 
Dlx1 Embryonic skeletal system development 
Wnt9a  Negative regulation of chondrocyte differentiation, 
Embryonic skeletal system morphogenesis 
Bmp4 Skeletal system development  
Hoxb5 Embryonic skeletal system morphogenesis 
Wwtr1 Osteoblast differentiation 
Igfbp3  Osteoblast differentiation 
Down regulated  
genes  
Col2a1  Chondrocyte differentiation, cartilage development  
Ptch1 Embryonic limb morphogenesis  
 
The third contrast provides genes that are differentially expressed between E13.5 
Sox9+/+ and Sox9+/- genotypes. The up-regulated set contains genes like Hoxd4, 
Acvr2b, Gnas, Igf1, Bmp4, Hoxb5 and Wwtr1 suggesting that these genes are 
expressed at lower levels in the absence of one of the copies of Sox9 in Sox9+/- cell 
population. The precise role of these factors in chondrogenesis is still under study.  
 
Table 2.2 C: List of up and down regulated genes in E13.5 Sox9 +/+ vs Sox9 +/- known to be 






           
 
 
All the probes in the heatmap have a p-value less than 0.01 in all the three contrasts.  
Many of these probes show a median expression level in the Sox9+/- samples 
compared to the Sox9+/+ and Sox9-/-samples.  
 
Fig 2.14: Heatmap image of 1088 probes, a fraction of the total number of probes that 





This preliminary analysis has provided us with a list of genes that are differentially 
expressed between E13.5 Sox9+/+, Sox9+/- and Sox9-/- genotypes. Further in-depth 
analysis and studies are required to identify the nature of interaction of Sox9 with 
these factors.   
2.3.4 The time effect:  The effect of time and genotype was analyzed using a 
factorial design for the Sox9 gene expression dataset. For this analysis, only the 
dataset for Sox9+/+ and Sox9+/- at E13.5 and E12.5 was used. The E13.5 Sox9-/- data 
was not included in this analysis as we didn’t have Sox9-/- data for E12.5 stage. The 
preprocessing method that was applied for the previous analysis was used for this 
analysis. This left us with a set of 8758 probes. The sample clustering was done using 
a hierarchical clustering method to look for outliers among samples.  
 





Figure 2.15 shows that the samples 13.5+/+3A, 3B, and 12.5+/+6A, 6B seem to cluster 
with a different group of samples. Because of that the above samples were not 
included in the subsequent analysis.  
For this analysis, the following contrasts were made: “E13.5 Sox9+/+ vs E12.5 Sox9 +/+ 
“, “E13.5 Sox9+/- vs E12.5 Sox9+/-“, and the interaction term “(E13.5 Sox9+/+-E13.5 
Sox9+/-)-(E12.5 Sox9+/+ - E12.5 Sox9+/-)”. And this analysis identifies the genes that are 
differentially expressed between the E13.5 and E12.5 stages for the Sox9+/+, Sox9+/- 
genotypes and the genes that are differentially expressed between the Sox9+/+ and 
the Sox9+/- genotypes and between the two time points. As in the previous section 
beadarray and limma packages were used for the analysis. The R code is given in 
Appendix 2.3. After fitting linear models and making contrasts, only those probes 
that have mapped Refseq id and GO terms were used for further analysis 
 Figure 2.16 shows the overlap between the differentially expressed probes amongst 
the three contrasts. Applying a cutoff for logarithmic fold change of 1 in both 
directions and a cutoff of 0.01 for adjusted p-value in the contrasts gave us an 
interesting set of genes. There are 57 such probes in the first contrast, 138 in the 
second contrast and 132 such probes in the third contrast. Refer Appendix 2.7, 2.8 
and 2.9 for the complete list of these genes. 
It is interesting to note that the highest fold change we observe in this analysis is 
around 3 to 4 fold difference for a very few genes compared to 32-35 fold difference 






Table 2.3 A, B and C lists some of the genes from these contrasts that are known to 
be involved in the osteo-chondrogenic specification pathway.   
Here the top ranked genes are different from that of the previous analysis. As it 
would be expected, the direct targets of Sox9 like Col2a1 or Sox5 are not present in 
this list. The first contrast gives us genes that are differentially expressed between 
E13.5 and E12.5 stage of Sox9+/+ cell population. Among a number of genes, there 
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Fig 2.16: Overlap among probes differentially expressed in the 






                   E13.5  Sox9 +/+ vs E12.5 Sox9 +/+  




GO terms  
Ltbp3 Skeletal system development, transforming growth factor 
beta receptor signaling pathway 
Mmp9  Skeletal system development, extracellular matrix 
organization 
Gdf5 positive regulation of chondrocyte differentiation 
Nfatc1 epithelial to mesenchymal transition, regulation of 
transcription, DNA-dependent 
Down regulated  
genes  
Hoxb4  Embryonic skeletal system morphogenesis, negative 
regulation of transcription.  Hoxb2  Embryonic skeletal system morphogenesis  
Acvr2b  Skeletal system development  
Hoxc9 Embryonic skeletal system morphogenesis 
Hoxb5  Embryonic skeletal system morphogenesis  
 
The expression levels of Ltbp3, Mmp9, Gdf5 and Nfatc1 are higher in E13.5 than in 
E12.5. The levels of factors such as Hoxb4, Hoxb2, Hoxb5 and Acvr2b are higher in 
E12.5 stage than in E13.5 stage. Further studies are required to elucidate the 
biological significance of this.  
Likewise the second contrast gives genes that are differentially expressed between 
E13.5 and E 12.5 stages of Sox9+/- cell populations. The expression levels of Mmp9 
and Col1A1 are higher in E13.5 stage. The levels of Hoxb4, Hoxd4, Acvr2b, Pax1, 
Hoxb5, Hoxd12 and Shox2 are higher in E12.5 than in E13.5 stage.  These are just a 
small fraction of genes in the list. The complete list includes several other genes 
including transcription factors, signaling molecules and extra cellular matrix 
components that may be involved in this developmental pathway. 
Table 2.3 A: List of up and down regulated genes in E13.5 Sox9 +/+ vs E12.5 Sox9 +/+ 







                   E13.5  Sox9 +/- vs  E12.5 Sox9 +/-  




GO terms  
 Mmp9  Skeletal system development, extracellular matrix 
organization 
 Col1a1  skeletal system development, osteoblast differentiation 
  Bgn extracellular matrix 
Down regulated  
genes  
  Hoxb4  Embryonic skeletal system morphogenesis, negative 
regulation of transcription 
  Hoxd4  Embryonic skeletal system morphogenesis  
  Acvr2b  Skeletal system development  
  Hoxc6 Embryonic skeletal system development  
  Pax1 skeletal system development 
Hoxb5  Embryonic skeletal system morphogenesis  
Hoxd12  Skeletal system development  
Shox2  Regulation of chondrocyte differentiation  
Gnas Skeletal system development  
 
The third contrast provides genes that are differentially expressed across the two 
time points and the two genotypes. Factors like Hoxd4, Chrd, Tgfb2, and Pax1 are 
among those in this list.   All these factors play important roles in embryonic skeletal 
system development.  
Only the genes that are known to be involved in the osteo-chondro specification and 
development pathway have been highlighted in these tables. Several other genes, 
whose GO terms are not related to the pathway, may be actually involved in the 
specification process.  
Table 2.3 B: List of up and down regulated genes in E13.5 Sox9 +/- vs E12.5 Sox9 +/- 







                   (E13.5  Sox9 +/+ - E13.5 Sox9 -/-)  
                 - ( E12.5 Sox9 +/+  - E12.5 Sox9 +/-) 
Up regulated  
genes  
Gene  Symbol  GO terms  
Hoxd4  Embryonic skeletal system morphogenesis  
Tbx5 Embryonic limb morphogenesis  
Nfatc1 Epithelial to mesenchymal transition 
Chrd Skeletal system development, Osteoblast differentiation.  
Tgfb2 Skeletal system development, Cartilage condensation 
Pax1 Skeletal system development 
Gnas Skeletal system development, Endochondral ossification 
Down regulated  genes  
 
 







It is important to note the limitations of the filtering method that has been used. For 
example Wnt5a is known to promote early chondrogenesis in vitro. It is among the 
genes that are differentially expressed. As its GO term does not contain any term 
related to the osteo-chondro specification pathway, it has not been listed in the 
table.   
This dataset contains a treasure trove of information that needs to be mined 
properly. It will be of interest to include E13.5 and E12.5 Sox9-/- data in the analysis. 
Perhaps in future, with the acquisition of E12.5 Sox9-/- data, we will be able to make 
other meaningful contrasts.  
 
 
Table 2.3 C: List of up and down regulated genes in (E13.5 Sox9 +/+ - E13.5 Sox9 +/-)-






   
 
 
2.3.5 Discussion  
The preliminary analysis of the dataset has given us an interesting set of genes that 
are differentially expressed between the wild type and mutant genotypes at 2 
different time points. This data needs to be validated by qPCR and in situ 
hybridization experiments.  
Fig 2.17: Heatmap image of 221 features that are differentially 





A lot more analysis needs to be done to reconstruct the gene regulatory network. 
High quality Sox9 binding data obtained from ChIP-seq experiments will provide 
additional information about gene interactions that will help in the construction of 
gene regulatory network involved in the chondrogenic specification pathway. The 
fact that many of the tissue specific enhancers in vertebrates are distant acting 
complicates the association of transcription factor binding to gene expression. This 
problem can be partially solved by using chromosome conformation capture (3C) 
techniques that analyzes interaction between functional elements over long 
distances. Development of refined methods for integrating transcription factor 
binding data and gene expression data from knockout and time-series experiments 





IDENTIFICATION OF ENHANCERS FOR THE DLX5/DLX6 BI-GENE CLUSTER 
 
3.1 Can you tell me where the switch is?  
Comparison of the genome of organisms from different clades has shown that there 
is no direct correlation between the number of protein coding genes present in the 
genome and the complexity of the organism. Moreover, most of these protein 
coding genes share a high degree of similarity. Surprisingly, the amount of non-
coding DNA present in the genome roughly correlates with the complexity of the 
organism (Taft et al., 2007). 
One of the ideas that has gained substantial amount of support from studies in 
invertebrates is that the evolution of the genomic regulatory code that controls 
development and by extension the evolution of developmental gene regulatory 
networks is the mechanism behind the evolution of different morphological forms 
(Carroll, S.B., 2005; Davidson E.H. et al., 2006). The genomic regulatory code mainly 
consists of the cis-regulatory elements that control the expression of transcription 
factors involved in development. The cis-regulatory elements act as processors that 
compute many spatial and temporal input cues along with the current regulatory 
state and produce an output. The output can take the form of switching on or off of 
the expression of the genes it regulates. To put it simply, cis-regulatory elements 
read the current regulatory state of the cell and the spatial environment in which it is 
present and either activate or repress the expression of the genes it controls. In 
bilaterian species, a single gene can have 5 -20 cis-regulatory modules that control 
when and where it is expressed (Davidson E.H. 2006). These modules may act singly 
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or in combinations to regulate the expression of its gene in a particular tissue at a 
particular time point. Identification of the cis-regulatory elements of developmental 
genes is a requisite for building GRNs (Smadar et al., 2006; Davidson E.H. et al., 2006) 
The cis-regulatory elements are mostly seen dispersed in the non-coding DNA in the 
vicinity of genes they are controlling. There are examples where the enhancers are 
present 1MB from the coding region (Lettice, L.A., 2003). Several strategies for 
identifying enhancers are being tested by several groups (Pennachio, L.A. and Rubin 
E.M. 2001). 
 The Comparative Genomics approach has been useful in identifying conserved non-
coding elements that can be assayed in vivo for regulatory activity. The basic 
assumption underlying this approach is that the functional non-coding regions are 
more resistant to random changes in its sequence, relative to the neutral DNA that is 
free to change (Kumar, S. 1998). Comparing the orthologous regions of the genome 
in different species that are evolutionarily separated allows the identification of 
conserved non-coding elements that may have a regulatory role in vivo. These 
conserved non-coding elements can be tested for their regulatory activity using 
various reporter constructs in various model systems (Woolfe, A. et al., 2005; 
Ghanem, N., 2003). 
One of the key considerations in the comparative genomics approach is the species 
that are selected for comparison. The relatively small divergence time among 
mammals necessitates the use of other vertebrates that are evolutionary distant, to 
make a useful comparison. Including teleost fishes in the comparison significantly 
decreases the number of CNEs that needs to be tested (Woolfe,A. et al., 2005). 
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Several studies have used this approach and have identified enhancers that drive 
tissue-specific expression of the genes under their control (Ghanem, N., 2003; 
Woolfe, A. et al., 2005).  
3.2 Identification of enhancers for the dlx5a/dlx6a bi-gene cluster in zebrafish 
 
Aim: The broad goal of this project is to develop a robust strategy to identify short 
and long range enhancers for genes that are involved in development and are 
expressed in a tissue specific manner.  In tune with other studies being done in the 
lab, the main focus is on developmental genes that are involved in the osteo-
chondro specification pathway. Specifically, this project aims to identify the 
enhancers that regulate the expression of dlx5a/dlx6a bi-gene cluster in developing 
zebrafish embryos. 
Approach:  We are using two approaches to identify enhancers. One approach 
involves modifying large genomic constructs like Bacterial Artificial Chromosomes 
(BAC) with a reporter gene and injecting the BACS, for identifying regulatory 
elements in the genomic region present in the injected BAC. Once an injected region 
has been found to drive the tissue specific expression of EGFP, the insert can be 
broken into fragments and cloned into a reporter construct and assayed for activity. 
The fragment that shows regulatory activity can then be characterized. In some 
cases, overlapping BACS may have to be injected to cover the regions containing 







The second approach to identify enhancers involve comparing orthologous regions 
containing the gene under study in the genomes of human, mouse, fugu, and zebra 
fish, and identify conserved non-coding elements that lie in the same synteny block. 
Once the Conserved Non-coding Elements (CNEs) that are to be tested are identified, 
the CNEs can be cloned into a reporter construct containing EGFP, driven by the 
basal promoter of the gene under study.  
The CNEs are identified from the conservation track of the UCSC browser. UCSC 




Fig 3.1: Schematic representation of BAC modification 
Fig 3.2: UCSC browser on Zebra fish genome (March 2006 assembly), showing 




The reporter construct is shown below. It contains the zebrafish basal promoter of 
the gene under study (1.5-2kb region 5’ end of the gene) driving the expression of 
EGFP. The CNEs to be tested are cloned into the multiple cloning sites in the vector. 
                  
 
Model system: 
Zebrafish as a model system offers several advantages. 
1) Zebrafish can be easily maintained in the laboratory. 
2) A large number of embryos are obtained from a single mating. 
3) External fertilization allows us to study its development from single-celled 
stage embryo in a dish. 
4) Transparent embryos allow us to view and monitor various developmental 
processes. 
5) The vector construct can be simultaneously injected into a number of 
embryos to get a statistically significant expression pattern of the reporter 
protein. 
6) The short generation time allows us to generate transgenic stable germ-line 
transmitters in less than a year (around 9-10 months).  
One of the disadvantages in using zebrafish embryos for enhancer assays is that 
rapid cell divisions during early embryonic development leads to a highly mosaic 
MCS 
Fig 3.3: Schematic diagram of the reporter construct 
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pattern of reporter gene inheritance and hence expression. This necessitates the use 
of multiple embryos and overlapping of the reporter expression domains to identify 
the domains in the embryo, where the putative enhancers are active. 
In contrast to the whole genome approach to identify enhancers, which look for 
global patterns that classify various functional elements in the genome, the gene-
centric approach involves the identification of enhancers using any one of the 
methods described above. In tune with other studies that are being done in the lab, 
where we are mainly interested in identifying enhancers for genes involved in the 
specification of osteo-chondro lineage. I picked the Dlx5/Dlx6 bi-gene cluster for 
developing this method. In zebrafish, this is called the dlx5a/dlx6a cluster.  
Dlx5/Dlx6 bi-gene cluster:  
Dlx genes code for homeo-domain transcription factors that are homologous to the 
Drosophila distalless gene (dll). In vertebrates, there are at least 6 genes that exist as 
pairs oriented in opposite directions. The genes have overlapping-expression 
domains and are involved in the development of forebrain, limbs, inner-ear, and in 
the specification of chondrocytes. The Dlx5/Dlx6 cluster performs multiple 
developmental functions and are involved in the development of forebrain, Apical 
















Dlx5/Dlx6 double knockout in 
mice causes craniofacial defects 
and phenocopies split hand split 
foot malformation (Robledo et 
al., 2002). Dysregulation of Dlx5 
in the ventral thalamus has been 
implicated in Rett syndrome 
(Horike et al., 2005). 
Fig 3.5: Wt and Dlx5/Dlx6 -/- E16.5 mouse 
embryos stained with alician blue reveals 
chondrogenic regions (adapted from Petra 
Kraus and Thomas Lufkin.2006) 
 
Fig 3.4: The dlx5a/dlx6a bi-gene cluster in the zebrafish genome.  The genes 




In mouse and zebrafish, dlx5a/dlx6a gene pair is expressed in the developing 
forebrain (diencephalon and telencephalon), pharyngeal arches, otic vesicle, 
olfactory placode, hypothalamus, and in the Apical Ectodermal Ridge (AER) of the 
developing limb and fin respectively. 
 
 





One of the well characterized enhancers for Dlx5/Dlx6 in both mouse and zebrafish is 
the inter-genic enhancer.  In mouse, it has been shown to drive reporter gene 
expression in the forebrain, Apical Ectodermal Ridge (AER) in the developing limb, 
and in the pharyngeal arches (Louis-Bruno et al., 2003). Ghanem et al. have shown 
that the inter-genic region between dlx5a and dlx6a has tissue specific enhancer 
activity in the forebrain in zebrafish embryos (Ghanem, N. et al., 2003) 
In the study by Louis-Bruno et al., a transgenic construct with mi561, one of the 
enhancers, driving cre-recombinase was injected in single cell stage mouse embryos 
Fig 3.6: In situ hybridization images for dlx5a in 48hpf zebrafish embryos. 
a) Lateral view showing expression in the diencephalon, pharyngeal 
arches, otic vesicle: b) Dorsal view showing expression in the 






and 4 transgenic founders that had 10-20 copies in a cell were paired with R26R. The 
embryos harvested at various stages showed β-gal activity in the forebrain, neural 
crest derived mesenchyme of craniofacial structures, and the AER of the developing 
limb (Louis-Bruno et al., 2003). 
The CNE mI561 that is closer to the 3’ end of Dlx6 has been shown to drive reporter 
gene expression in the diencephalon, telencephalon, mandibular pharyngeal arch, 
neural crest derivatives and the AER. Endogenous Dlx5 and Dlx6 are also expressed 
in the otic placode. The enhancer driving Dlx5/Dlx6 in this domain has not been 
characterized so far. For a detailed analysis of this enhancer and the endogenous 
expression patterns of Dlx5/Dlx6 in mouse at various developmental stages, refer to 
Louis-Bruno et al., 2003.  
In another study by Ghanem et al., the two CNEs in the intergenic region have been 
shown to drive reporter gene expression in transgenic assays in both mouse and 
zebrafish. The mouse intergenic region has also been shown to drive reporter gene 
expression in zebrafish when cloned along with zebrafish dlx6a promoter driving GFP 
expression. The sequence similarity between the mouse and zebrafish intergenic 
sequences is around 80%. They have also reported that the zebrafish intergenic 
element drives lacZ expression in transgenic reporter assays (Ghanem,N.et al., 2003). 
In all these assays, the reporter gene expression mimics the endogenous Dlx5/Dlx6 
expression.  
GENSAT (Gene Expression Nervous System Atlas), a large scale project for classifying 
cell types in the mouse central nervous system based on expression profile of genes 
uses BAC modification and transgenic technology for detailed profiling of expression 
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pattern of genes in the CNS. The BAC containing the gene of interest and a 
substantial amount (100-250kb) of genomic region flanking the gene is modified in 
such a way that EGFP and poly-adenylation sequence is inserted just before the start 
codon of the gene of interest. The modified BAC is injected in to single-cell staged 
mouse embryos and re-implanted into pseudo-pregnant females. The embryos are 
harvested at different embryonic stages and sectioned for observation under 
confocal fluorescence microscope for detailed profiling of EGFP expression, which 
mimics the expression of the gene under study (Gong et al., 2003). Detailed 
protocols for BAC modification and transgenic methods can be found in the GENSAT 
website. 
For Dlx5, the mouse BAC RP24-260F14 was modified with EGFP and injected to 
generate transgenic embryos for EGFP expression profiling (http://www.gensat.org).  
The EGFP expression shows that the 144kb genomic region including and flanking 
the Dlx5 gene contains the regulatory elements of Dlx5 that drives the gene in the 
CNS.  No such data is available for the other domains of Dlx5 expression. So it is not 
clear whether the enhancers active in the other expression domains of Dlx5 are 
present in this 144kb region. The enhancers active in the otic placode and robust 
enhancers in the AER for Dlx5/Dlx6 have not been characterized.  
To identify other enhancers for Dlx5 in the rest of the endogenous expression 
domains and develop a strategy for the identification of long and short range 
enhancers for developmental genes, we decided to use both BAC modification and 
CNE reporter assay. The initial studies are to be done in zebrafish and once the 
putative enhancers are identified, these can be tested in mouse. 
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3.3 Methods  
In vivo assay of Conserved Noncoding Elements (CNEs) 
The phastcons predicted conserved noncoding elements that fall within a synteny 
block in human, mouse, and zebrafish alignments were picked. Phastcons is a phylo-
HMM based program for detecting conserved regions in multiple sequence 
alignments. A phylo-HMM model is fit to the data by maximum likelihood method 
and then conserved elements are predicted based on this model (Siepel, A. et al., 
2005). The conservation track in the UCSC browser is based on the Phastcons 
program. Each of the predicted conserved element is associated with a log-odds 
score. The table below shows the putative enhancers and their genomic location as 
modeled in the UCSC genome browser.  
 
Fig 3.7: Sections from E15.5 transgenic embryos showing EGFP 
expression in the cerebral cortex. EGFP expression was also observed in 
the ventral thalamus and hypothalamus. Images were obtained from 
GENSAT (http://www.gensat.org).  
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CNEs  Position in Zebra 
fish chromosome 
19 (march 2006 
assembly)  
Position relative to 
dlx5a 
Conserved in  
Inter-genic region 




of dlx5a/dlx6a  
Zebrafish, mouse, 
and human (ZMH)  
CNE1  41676338-
41676592  
5’UTR of dlx6a  (ZMH)  
CNE2  41675210-
41675714  
8kb downstream  (ZMH)  
CNE3  41672758-
41673262  
10kb downstream  (ZMH)  
CNE4  41653877-
41654437  
30kb downstream  (ZMH)  
Basal promoter 41683513-
41684607 




The putative enhancers were amplified from zebrafish (zf) genomic DNA and zf 
modified BAC as the template by PCR (using primers provided in Appendix_3.1) and 
cloned into the basal reporter vector with a 1.1 kb fragment 5’ of dlx5a driving EGFP. 
The intergenic element was cloned using KpnI-Hindlll restriction. The rest of the 
CNEs were cloned into KpnI site of the basal reporter construct. The CNE-reporter 
constructs were prepared using Qiagen-mini prep kit and quantified and quality 
checked using nano-drop. Only those preparations that were of good quality were 
used for microinjection. 
Table 3.1: List of CNEs to be tested and their genomic positions along with the 






The cloned reporter vectors (30ng/µl preparations) were injected into single-cell 
stage zebrafish embryos and the injected embryos were assayed for EGFP expression 
at 48hpf. The EGFP expression domains from multiple embryos were marked on a 
drawing template of 48hpf zebrafish embryo and the percentage of embryos that 
showed EGFP expression in a specific domain were tabulated. This drawing template 
was obtained from the CONDOR website (http://condor.fugu.biology.qmul.ac.uk/).  
3.4 Results & Discussion: The EGFP expression pattern for each of the CNE: reporter 
vector and the basal reporter construct and the table showing the fraction of 
embryos expressing EGFP in each of the tissue domains is given below. Each of the 
CNEs in relation to the dlx5a/dlx6a bigene cluster in the zebrafish genome (UCSC 
genome browser) is also given. 





















The basal promoter for dlx5a 
Fig 3.9A: UCSC track showing the basal promoter in the zebrafish genome  
Fig 3.9B: Template drawing showing EGFP expression in the various domains of 
48hpf zebrafish embryo.  Legend: A1-3: Forebrain, B1-3: Midbrain, C1-2: 
Hindbrain, D: Spinal cord, G: Otic vesicle, H: lateral line, J: Somitic muscles, K: 
blood islands, L: heart/pericardium, O: fin, P: Pectoral fin, Q: tailbud, R: 
Yolk/hatching gland, S: between yolk and brain, T: between spinal cord and yolk 





Expression domains No of embryos that show 
EGFP expression in 
specific domains 
Percent fraction of the 
total no of EGFP 
expressing embryos 
Notochord & somites 2/34 5.8% 
Forebrain 2/34 5.8% 
Midbrain  0/34 0% 
Pharyngeal arches 1/34 2.9% 
Median fin 2/34 5.8% 
Pectoral fin 0/34 0% 
 
As it would be expected from just the basal promoter, the above table shows that 
there was no tissue specific expression in any of the domains of dlx5a/dlx6a 
expression. This basal reporter construct was injected several times and similar 
results with no tissue specific expression of EGFP was observed. 
 





Table 3.2: Table of the fraction of embryos showing EGFP expression in the various 
domains in 48hpf zebrafish embryo injected with basal reporter vector  















EGFP expression in 
the AER of pectoral 
fin and the 
forebrain  
Fig 3.10B: Template drawing showing EGFP expression in 48hpf zebrafish 
embryo injected with basal reporter vector + intergenic element 
Fig 3.10C: Fluorescence microscope images of 48hpf zebrafish 
embryos showing EGFP expression in the forebrain and AER of 









No of embryos that show 
EGFP expression in 
specific domains 
Percent fraction of the 
total no of EGFP 
expressing embryos 
Notochord & somites 41/67 61% 
Forebrain 52/67 78% 
Midbrain  2/67 2.9% 
Pharyngeal arches 3/67 4.4% 
Median fin 21/67 31% 
Pectoral fin 11/67 16.4% 
 






The intergenic element shows strong enhancer activity in the forebrain. Around 78% 
of the injected embryos show EGFP expression in the forebrain. And interestingly, 
61% of the injected embryos show EGFP expression in the somites which is not an 
endogenous expression domain of the dlx5a/dlx6a gene pair. Studies described in 
Fig 3.10D: EGFP expression in the 
dorsal thalamus in 72hpf zebrafish 
embryo injected with intergenic 
element + basal construct under 
confocal fluorescence microscope. 
Table 3.3: Table of the fraction of embryos showing EGFP expression in the 




the introduction section too have found strong enhancer activity for this element in 
the forebrain, but none of them suggest any reporter expression in the somites. 











This element which has portions of the 5’-UTR of dlx6a and the basal promoter of 
dlx6a may not be strictly classified as a CNE. We wanted to test whether the 
combination of this element and the basal promoter of dlx5a show any tissue 
Fig 3.11A: UCSC genome browser track showing CNE 1 in the zebrafish genome 
Fig 3.11B: Template drawing of 48hpf zebrafish embryo showing EGFP expression 








Expression domains No of embryos that show 
EGFP expression in 
specific domains 
Percent fraction of the 
total no of EGFP 
expressing embryos 
Notochord & somites 3/43 6.9% 
Forebrain 16/43 37.3% 
Midbrain  1/43 2.3% 
Pharyngeal arches 2/43 4.6% 
Median fin 17/43 39.5% 
Pectoral fin 0/43 0% 
 
EGFP expression in the forebrain of the 38% of injected embryos is not strong as it 
was observed with the intergenic element. And most of the expression was only in 
the exterior and may not be in the forebrain at all.  





Table 3.4: Table of the fraction of embryos showing EGFP expression in the various 
domains of zebrafish embryos injected with basal reporter vector + CNE1 











Expression domains No of embryos that show 
EGFP expression in 
specific domains 
Percent fraction of the 
total no of EGFP 
expressing embryos 
Notochord & somites 20/70 28.6% 
Forebrain 7/70 10% 
Midbrain  8/70 11.4% 
Pharyngeal arches 13/70 18.6% 
Median fin 17/70 24.3% 
Pectoral fin 0/70 0% 
 
As the table suggests, there was no strong enhancer activity in any of the domains of 
expression of dlx5a/dlx6a. The strongest activity in this case seems to be in the 
Fig 3.12B: Template drawing of 48hpf zebrafish embryo showing EGFP 
expression in zebrafish embryos injected with basal reporter vector + CNE2 
Table 3.5: Table of the fraction of embryos showing EGFP expression in the various 
domains of zebrafish embryos injected with basal reporter vector + CNE2 
64 
 
somites and median fin that are not expression domains of the gene pair. Hence this 
element may not be of interest to us.   
 














Fig 3.13A: UCSC genome browser track showing CNE3 in the zebrafish 
genome 
Fig 3.13B: Template diagram of 48hpf zebrafish embryo showing EGFP 
expression in the various domains of embryos injected with basal reporter 





Expression domains No of embryos that show 
EGFP expression in 
specific domains 
Percent fraction of the 
total no of EGFP 
expressingembryos 
Notochord & somites 21/95 22.1% 
Forebrain 1/95 1% 
Midbrain  2/95 2.1% 
Pharyngeal arches 8/95 8.42% 
Median fin 4/95 4.2% 






This element doesn’t show any strong tissue specific enhancer activity. The 
interesting observation is that of those injected embryos that showed EGFP 
expression in the pectoral fin. Even though it is a very small fraction, it suggests the 
possibility that this element may act together with other elements to drive the gene 
expression in this specific domain. 
EGFP expression in the AER 
of pectoral fin in 48hpf 
zebrafish embryo injected 
with basal reporter vector 
+ CNE3 
Table 3.6: Table showing the fraction of embryos expressing EGFP in the various domains 
of 48hpf zebrafish embryos injected with basal reporter vector + CNE3 
Fig 3.14: 48hpf Zebrafish embryo injected with 




All the constructs were injected in 2 to 3 batches and were found to have a similar 
expression pattern to the results shown above.  
In vivo assay of large genomic region  
The zebrafish BAC CH211-57N3 was modified in such a way that an EGFP-neo 
cassette is introduced just in front of the ATG of the dlx5a gene using the 
recombination based RED/ET method. No tissue specific expression of EGFP was 
observed in embryos injected with the modified BAC. Necessary quality control was 
done to ensure that the correct BAC was modified and injected. Modified BACS for 
other genes showed tissue specific expression of EGFP which suggests that the 
injection method was correct. It is not clear why the modified BAC failed to show any 
activity. 
Discussion 
The in vivo assay of CNEs has identified the intergenic element as a forebrain 
enhancer as it has been shown by other studies. Both the intergenic element and 
CNE 3 drove EGFP expression in the AER of pectoral fin in a very small fraction of the 
injected embryos. It is possible that some of these elements may function together 
in driving gene expression. The rest of the elements that were tested failed to show 
any tissue specific regulatory activity. Testing combinations of elements may suggest 
the function of the other CNEs. And the result from modified BAC injection doesn’t 
suggest anything about the enhancers active in other endogenous expression 
domains of the dlx5a gene. Testing other BACs covering similar genomic regions may 
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indicate the presence or absence of regulatory elements within that region. Further 
studies need to be done to identify all the enhancers for dlx5a/dlx6a bi-gene cluster. 
As a strategy, this method of identifying CNEs and in vivo assay for enhancer activity 
seems to work, as we have identified one very strong forebrain enhancer. This is a 
very small dataset to draw conclusions about the efficacy of this approach. Other 
large scale studies, using a similar approach have successfully identified many 
enhancers for a number of genes (Woolfe, A. et al., 2007). However, recent studies 
suggest that merging whole-genome binding data of basic transcriptional co-
activators like P300 with conservation data in selecting putative enhancers 
significantly improves the efficiency of this approach (Axel Visel et al., 2009). This 






Epitope tagging of Oct4 for mapping pluripotency network 
 
4.1 Introduction 
Mouse Embryonic Stem (ES) cells and the cells of the Inner Cell Mass (ICM) of 
blastocysts are pluripotent. Pluripotency refers to the ability of the cells of the ICM 
to give rise to all the cell types present in the embryo (Smith, A. 2005). This ability of 
embryonic stem cells and its potential applications to biomedical science has spurred 
an enormous interest in stem cells, leading to several studies to understand the 
molecular and cellular basis of the properties of stem cells (Niwa, H. 2007). In 
addition to their property of pluripotency, stem cells can be maintained in culture 
indefinitely. This property has to a large extent made such studies possible (Evans, 
M.J. et al., 1981; Smith, A.2005) 
Several studies have shown that pluripotency is maintained during ES cell self-
renewal through the prevention of differentiation and promotion of proliferation.  ES 
cells can only differentiate directly into 3 cell types: primitive endoderm, primitive 
ectoderm and trophectodermal cells. The expression of certain transcription factors 
drives the differentiation of ES cells into specific pathways. To maintain pluripotency 
these factors have to be repressed (Smith, A. 2005; Niwa, H. 2007; Pierce, G.B.,et al. 
1988). 
LIF (Leukemia Inhibitory Factor), a member of the IL-6 cytokine family has been 
shown to be essential and sufficient to maintain pluripotency in mouse embryonic 
stem cells. Oct4 is a pivotal regulator of pluripotency and has been shown to repress 
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a number of genes that induce differentiation (Nichols, J.et al., 1998; Niwa, H.et al., 
1998). It has been shown to act along with other factors, Nanog and Sox2, which are 
also important regulators of pluripotency (Loh et al., 2006; Rodda, D.J. et al., 2005; 
Boyer,L.A. et al.,2005) These 3 transcription factors form the core transcriptional 
regulatory network in ES cells (Boyer et al., 2005). Recent studies have shown that 
the transfection of just 4 factors (Oct4, Sox2, Klf4 and c-Myc) can induce 
pluripotency in fibroblasts. These induced pluripotent stem cells give rise to a 
healthy mouse embryo on injection into the blastocyst and re-implantation in to 
pseudo-pregnant mouse.  
 
 
                                                                                         
The transcription factors that maintain pluripotency in the cells of the inner cell mass 
and those that drive the differentiation of these cells into specific lineages are shown 
in Figure 4.1. Cdx2 drives some of the cells of the morula into the trophectodermal 
lineage. Gata6 drives some of the cells of the epiblast in to the primitive endodermal 
lineage (Niwa, H. 2007). 
Fig 4.1: Pluripotent lineages in mouse embryo (figure taken from Niwa, H.2007) 
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In eukaryotic systems, most of the transcription factors have been shown to act 
minimally as hetero-dimers and mostly as multi-protein complexes (Hampsey M et 
al., 1999). Advances in mass-spectrometry (MS) based technologies have helped in 
building global interactome maps in yeast and for specific modules in other model 
systems (Gavin, A.C. et al., 2002; Ho, Y. et al., 2002; Shuye et al., 2007). 
For constructing interaction maps for specific functions, a protein known to be 
involved in a specific function is tagged with epitope tags and affinity purified under 
native conditions. Following the purification of complexes, the proteins are 
separated in an SDS-PAGE gel. The individual bands are excised and subjected to in-
gel trypsin digestion, before LC/MS analysis. Peptide mass fingerprints or partial 
sequencing data obtained from MS are used for mining protein databases to find 
proteins present in the complex. In an iterative fashion, the identified interaction 
partners can be tagged and their interaction partners identified. Several algorithms 
are available to convert the MS output in to interaction maps (Pu et al., 2007; 
Downard, M.K. 2006). 
The protein interaction network for pluripotency was mapped by Wang et al., using 
this approach. In their study, they tagged Nanog, a pivotal regulator of pluripotency. 
By using Tandem Affinity Purification (TAP) followed by mass-spectrometry, they 
have identified its interaction partners. In an iterative fashion, they have tagged 5 of 
its high confidence interaction partners and using the same approach identified their 







The broad goal being pursued along with others in the lab is to map the pluripotency 
network in mouse ES cells. For use as bait proteins, we picked a list of transcription 
factors that have been shown to be important for pluripotency by several studies. 
Table 4.1 shows a list of transcription factors important for pluripotency. For 
optimizing the Tandem Affinity Purification (TAP) protocol and to test two different 
tandem tags, we decided to work initially with one factor. For this purpose, we chose 
Oct4. 
Mouse Oct4 is a 352 amino acid protein belonging to class V of POU proteins. It has 
been shown to be a pivotal regulator of pluripotency. Initially Oct4 is expressed in 
the totipotent (1-8 cell) embryo, and as development progresses its expression is 
restricted to the cells of the inner cell mass. Oct4 is down regulated in the 
Fig 4.2:  Protein interaction network for pluripotency 
(figure taken from Wang et.al, 2006) 
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trophectodermal lineage and over-expressed in the primitive endodermal lineage 
(Niwa, H. et al., 2006; Pesce and Scholer. 2001). 
 
 Gene Name  Accession Number  References  
Pou5f1 (Oct4) NM_013633  Pritsker et al.,2006; 
Wang,J et al.,2006  
Nanog  AF507043  Pritsker et al.,2006  
Sox2  NM_011443  Wang,J.et al.,2006 
Sox15  NM_009235  Wang,J.et al.,2006 
Cdx2  NM_007673  Wang,J.et al.,2006  
Dax1/Nr0b1  NM_007430  Wang,J.et al.,2006  
Rex1/Zfp42  NM_009556  Pritsker et al.,2006  
Cited2  NM_010828  Pritsker et al.,2006  
Chop10/Ddit3  NM_007837  Pritsker et al.,2006  
C-myc  NM_010849  Takahashi et 
al.,2006  
 
Table 4.1: List of transcription factors important for pluripotency 
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We also wanted to test different tags (that are to be fused with transcription factors) 
for their efficiency in pulling down high confidence interaction partners by native 
tandem affinity purification.  
Hypothesis:  The modular nature of transcriptional regulatory networks suggests 
that there exists a module of interacting transcription factors that confers the 
property of pluripotency in mouse embryonic stem cells. Several studies have shown 
the existence of such modular networks for pluripotency (e.g. Wang,J. et al., 2006).  
When we started, we had several other questions to test:  
1) Is it possible to over-express (above endogenous levels) the transcription 
factors known to be involved in pluripotency in ES cells, as some factors like 
Oct4 show dosage effects? 
2) Is it possible to generate stable cell lines expressing the pluripotency factors –
fused with the tandem tags that we are testing? 
3) Is it possible to use this over-expression of tagged proteins followed by 
Tandem affinity purification/ Mass Spectrometry (TAP-MS) analysis as a high-
throughput method for building the interactome map for pluripotency? 
Aim: The specific goal of this project is to generate stable ES cell lines expressing 
epitope tagged Oct4 for TAP-MS analysis and compare the efficiency of this method 
with the homologous recombination method for generating epitope tagged Oct4 
expressing cell lines (which is being done by other members in the lab) in their 
effectiveness in pulling high confidence interaction partners for Oct4.  
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Approach:  The approach we are using is to fuse the sequence coding for the tags to 
the 3’ end of the coding sequence of transcription factors in a vector construct. By 
electroporating the vector, stable ES cell lines over-expressing these tagged proteins 
were generated.  Then these tagged proteins can be used as baits to pull down 
associated transcription factors by orthogonal tandem affinity purification and 
identify the associated factors by mass-spectrometry. We use orthogonal tandem 
affinity purification to reduce background and improve the purification grade. Here 
orthogonal means that the first affinity purification is based on ligand interaction 
and the second purification is based on antibody interaction.  
4.2.1 Method and Results:    
Epitope tags: For Orthogonal tandem affinity purification, we wanted to test 2xflag-
TEV-BAP and Flag-PreScission protease -TEV-BAP tags. Flag is an eight amino acid 
peptide tag that can be used for immuno-affinity purification (Einhauer et al., 2001). 
TEV site has the recognition sequence for Tobacco Etch Virus protease. TEV protease 
cleavage is used to elute the proteins bound to streptavidin-agarose column under 
non-denaturing conditions (Knuesel et al., 2003). BAP (Biotin Acceptor Peptide) is a 
15 amino acid peptide. Biotin ligase (BirA) catalyzes the addition of biotin to a lysine 
residue in the BAP peptide. This tag can be used for affinity purification with 
streptavidin-agarose column. Prescission protease site (pre) has the recognition 
sequence for Prescission protease. Prescission protease specifically cleaves between 
the Gln & Gly residues of the recognition sequence of Leu-Glu-Val-Leu-Phe-Gln/Gly-




Vector construct for C-terminal tagging:   
The cDNA of the transcription factor to be tagged was cloned into the SalI site in the 
vector given below. The expression is driven by the CAG promoter (a very strong 
promoter in ES cells). In this construct, the CAG promoter drives the expression of 
the tagged protein, hBirA (which is a humanized form of biotin ligase that catalyzes 
the addition of biotin to the Biotin acceptor peptide (BAP) in the tag) and eGFP 
(enhanced Green Fluorescent Protein). The 3 coding regions are separated by 2 IRES 
sequences. An Internal Ribosomal Entry Site (IRES) sequence allows 5’-cap 
independent translation from the tri-cistronic transcripts. The construct has 
Kanamycin/Neomycin resistant marker driven by SV40 promoter that allows 
selection in both bacteria and stem cells. 
       
 
 
i)  Cloning of oligos coding for tandem tags: Both 2xflag-TEV-BAP and Pre-flag-
TEV-BAP oligos coding for the tags were cloned into the vector. The sequence 













Ase I (8 )
Fig 4.3: Schematic diagram of the vector used for tagging 
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of the oligos is given below. The double-stranded oligos were synthesized by 
annealing the individual strands at 68°C. And the oligos were cloned in to the 
vector using In-fusion dry-down PCR cloning method (Clontech). The 

























ii) Oct4 cDNA was prepared from total RNA extracted from V6.4 ES cells by 
Reverse Transcription PCR using gene specific primers. Total RNA extraction 
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was done using the Qiagen RNeasy mini kit. Refer appendix 2.1 for the 
protocol. The difference in protocol here being the number of cells used for 
purification. Correspondingly, 700µl of Buffer RLT was used for lysis. The 
primers used for gene specific reverse transcription are given below: 
Forward- 5’- ATAT GTCGAC CTTCCCC ATG GCT GGA CAC CTG GCT-3’ and 
Reverse- 5’- CCGC GTCGAC ACC CCA AAG CTC CAG GTT CTC TTG TCA-3’. 
 
iii) The Oct4 cDNA was cloned in to the SalI site of both the diflag and the 
prescission protease tag vectors. And 10ug of the vector was electroporated 
in to V6.4 ES cells. The cells were plated in 3x10cm plates and selected in 
different concentrations of G418 for 14 days. Following which 11 clones were 
picked and expanded for the Oct4-2xflag-TEV-BAP construct. Out of the 11 
clones only 7 clones were viable.  Around 36 clones were picked for the Oct4-
Pre-Flag-TEV-BAP construct. Out of this only 18 clones were viable.   
 
iv)  All the viable clones (7 clones  for the 2xflag-TEV-BAP construct and 18 
clones for the Pre-Flag-TEV-BAP construct  were screened for the expression 
of tagged Oct4 and eGFP by western blotting and probing with the following 
anti-bodies. 
1) anti-Oct4  
2) anti-flag (Sigma-Aldrich anti-flag M2  1:1500 in 5%milk in TBST)           
3) Streptavidin-HRP (NEN 1:7500 in 5% BSA in TBST , BD living colors ) 
4) anti-eGFP (1:2500 in 5% milk in TBST, and Oct4 N19 from Santa Cruz 
1:10,000 in 5%milk in TBST) 
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4.2.2 Screening results for the Oct4-2xflag-TEV-BAP construct: Out of the 7 clones 
that were screened for the expression of Oct4-2xflag-TEV-BAP and EGFP, 3 clones 
(A4, 7, &9) showed expression of EGFP, bio-Oct4, and flag-Oct4. Two clones (A4 &A7) 
didn’t show any Oct4 when probed with N19 anti-Oct4 antibody. These 2 clones 
differentiated on subsequent passages. Only one clone (A9) that showed the 
expression of both tagged Oct4 and EGFP was viable and showed normal ES cell 
phenotype. The screening results are shown below: 
                        Wt v6.4                                                 A9 (Oct4-Diflag-TEV-BAP) 





Figure 4.5 shows the western blot probed with anti-flag antibody. The bands at 
around 50kda in samples A4, A7 and A9 show the expression of Oct4-2xflag-TEV-
BAP. The band in lane 10 shows the presence of flag-his-Oct4 whose MW is similar to 
that of Oct4-2xflag-TEV-BAP. Lane 11 shows flag-EGFP in the sample. The samples in 
lane 10 and 11 were used as a positive control for anti-flag probing.  
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Fig 4.5: Screening for Oct4-2xflag-TEV-
BAP; Blot probed with anti-flag. 




Figure 4.6 shows the blot probed with anti-EGFP antibody. The bands in lanes 3, 4 
and 7 corresponding to samples A4, A7 and A9, that showed positive for Oct4-2xflag-
TEV-BAP, at around 30kda (27kda for EGFP) show the expression of EGFP in these 
samples. The sample in lane 10 shows the presence of flag-EGFP and was used as a 






Figure 4.7 shows the blot probed with streptavidin-HRP. The bands at 105 and 75kda 
seen in all the samples are biotinylated proteins present in mouse ES cells. The bands 
at around 50kda in lanes 3, 6, and 7 corresponding to samples A4, A7, and A9 show 
the presence of biotinylated Oct4. These 3 samples were also positive for flag and 
EGFP. Lane 10 shows the biotinylated ladder. 
 

























Figure 4.8 shows the blot probed with anti-Oct4. We would expect Oct4 band to be 
seen in all the samples as all the samples were prepared from ES cell cultures. 
Probing with this anti-Oct4 antibody always shows 2 bands for Oct4. The absence of 
the bands in lanes 4 and 5, corresponding to samples A4 and A7, is striking as the 
same samples showed positive for flag-Oct4, EGFP and biotinylated-Oct4. And 
interestingly these 2 cultures were not able to be cultured continuously and started 
differentiating after few passages.  
4.2.3 Screening results for the Oct4-pre-flag-TEV-BAP construct:  
Out of the 18 clones that were screened for the expression of tagged Oct4 and EGFP, 
8 clones showed expression of EGFP and only one clone (28 BcpreA1) showed bio-
Oct4. None of the clones showed flag-Oct4. Even the one clone that showed the 
expression of bio-Oct4 didn’t show any flag-Oct4, when probed with anti-flag, which 
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Fig 4.8: Blot probed with anti-Oct4 
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is very confusing as the BAP peptide is present at the C-terminal end next to the flag 
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Fig 4.9A: Screening for Oct4-pre-flag-TEV-
BAP; Blot probed with anti-flag 
Fig 4.9B: Blot probed with anti-flag 
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Figures 4.9A and 4.9B (above) show blots probed with anti-flag antibody. While 
several samples show a background band at 35kda, only the positive control (lane 8) 
shows a band at around 50kda which is the expected MW of Oct4-pre-flag-TEV-BAP. 
The positive sample A9 from the previous screening was used as the positive control. None 
of the samples screened for Oct4-pre-flag-TEV-BAP showed a band at the expected size 
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Fig 4.10A: Blot probed with anti-
EGFP (1:2500 in 5%milk in TBST) 




Figures 4.10 A and 4.10B (above) show blots probed with anti-EGFP. Surprisingly, 
many samples showed bands at the expected band size of 27kda for EGFP. Lanes 2, 
4, 5 in 4.10A and lanes 2, 7, 9, 10, 11 in 4.10B show bands at the right size for EGFP 
when probed with anti-EGFP antibody. It is important to note that none of these 
samples that are positive for EGFP showed any band for Oct4-pre-flag-TEV-BAP when 
probed with anti-flag antibody. 
 






Figures 4.11A (above) and 4.11B (below) show blots probed with streptavidin-HRP. 
Bands at 105 and 75kda are the endogenously biotinylated proteins present in 
mouse ES cells and is seen in all the samples in the blot. The 50kda band in lane 6 is 
the biotinylated Oct4-2xflag-TEV-BAP and sample 28 in lane 11 in 4.11A and lane 9 in 
4.11B show band at the right MW expected of biotinylated Oct4-pre-flag-TEV-BAP. It is 
important to note that this sample was also positive for EGFP, but did not show any band at 
the right MW when probed with anti-flag.  
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3- 5 BcpreA1 
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Oct4-2xflag-TEV-BAP Oct4-pre-flag-TEV-BAP 
Fig 4.11A: Blot probed with streptavidin-HRP 
85 
 




4.3 Discussion:   For the Oct4-2xflag-TEV-BAP construct, only one clone showing the 
expression of tagged protein and EGFP has been obtained. For the Oct4-Pre-flag-
TEV-BAP construct, none of the clones have been shown to be positive for both the 
tags.  This shows that even though this method of generating stable lines of mouse 
embryonic stem cells that over-express tagged Oct-4 works (and possibly with other 
transcription factors that are yet to be tested), it is very inefficient. Our initial idea 
was to develop this method as a faster approach compared to the knock-in approach 
that is very time consuming. But the relative inefficiency of this method has forced 
us to abandon this approach, despite initial optimism.  
One of the explanations for the low efficiency of this approach could be the dosage 
effects some of these factors have been shown to have. Over-expression of Oct4 
above 50% of its endogenous levels in ES cells induces its differentiation into 
primitive endodermal lineage (Niwa.H. et al., 2000). So only those clones that over-
express the tagged Oct4 well below 50% of the endogenous levels will be able to 
  150 
   75 
   50 
   35 
1-wt V6.4         
2-1BcpreA1   
3-3BcpreA1    
4-8BcpreA1   
5-blank           








 1        2      3        4     5     6       7     8      9     10 
Oct4-pre-flag-TEV-BAP 




maintain ES cell phenotype. It is not known if the other factors that are involved in 
pluripotency also show dosage effects.  
A knock-in approach by homologous recombination for introducing and expressing 
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Appendix 2.1 
Protocol for purification of total RNA from sorted cells using Qiagen RNeasy mini kit 
 
Things done before extraction: 
10 µl of β-mercaptoethanol was added to 1ml of Buffer RLT. And 70% alcohol was prepared 
using RNase-free water.  
 
1) The sorted cells were collected in leibovitz medium with 5% FCS. The suspension was 
centrifuged at 2000 rpm for 3 minutes at 4°C and the cells were pelleted. The 
supernatant was carefully aspirated out. 
2) 350µl of Buffer RLT was added to the pellet. 
3) The lysate was homogenized by passing it through 21 gauge needle fitted to RNase 
free syringe for 5 times. 
4) 350µl of 70% alcohol was added to the homogenized lysate and was mixed 
thoroughly by pipetting. 
5) 700 µl of the sample was transferred to an RNeasy spin column placed in a 2ml 
collection tube. The lid of the spin column was closed and it was centrifuged for 30 
seconds at 10,500 rpm. The flow -through was then discarded. 
6) 700 µl of Buffer RW1 was then added to the spin column and centrifuged for 30 
seconds at 10,500 rpm. The flow-through was then discarded. 
7) 500 µl of working solution of Buffer RPE was added to the spin column and 
centrifuged for 30 seconds at 10,500 rpm. The flow-through was then discarded. 
8) Then 500 µl of working solution of Buffer RPE was added to the spin column and 
centrifuged for 2 minutes at 10,500 rpm. 
9) The RNeasy column was then placed in a new RNase-free 1.5ml centrifuge tube. 30 
µl of RNase-free water was added to the column. It was then centrifuged for 1 
minute at 10,500 rpm to elute the RNA. 
- 
Appendix 2.2 
## R-code used for analysing E13.5 Sox9 microarray data  
##Beadarray & Limma package for differential gene expression analysis  












ind = apply(Detection(sox9data.quantile)>0.99, 1, all) 










"12.5+-" "12.5++" "13.5--" "13.5+-" "13.5++" 
"1" 0 0 0 1 0 
"2" 0 0 0 1 0 
"3" 0 0 0 1 0 
- 
"4" 0 0 1 0 0 
"5" 0 0 1 0 0 
"6" 0 0 0 1 0 
"7" 0 0 0 1 0 
"8" 0 0 0 1 0 
"9" 0 0 1 0 0 
"10" 0 0 1 0 0 
"11" 0 0 0 0 1 
"12" 0 0 0 0 1 
"13" 0 1 0 0 0 
"14" 0 0 0 0 1 
"15" 1 0 0 0 0 
"16" 1 0 0 0 0 
"17" 0 0 0 0 1 
"18" 0 1 0 0 0 
"19" 0 1 0 0 0 
"20" 0 1 0 0 0 
"21" 1 0 0 0 0 
"22" 1 0 0 0 0 
"23" 0 0 0 0 1 
"24" 0 0 0 0 1 
"25" 0 1 0 0 0 
"26" 0 1 0 0 0 
"27" 1 0 0 0 0 




"13.5++vs13.5--" "13.5+-vs13.5--" "13.5++vs13.5+-" 
"1" 0 0 0 
"2" 0 0 0 
"3" -1 -1 0 
"4" 0 1 -1 





















#### Code for getting GO information done using getOntology,etc from annotate package: 
got<-sapply(go,dropECode,c(“IEA”,”ND”)) 
gotl<-rep(0,number) 




## gotl contains all the information GO_ID , Ontology, Evidence for each of the probe ids. 
## Code to get GO_IDs of probes (GO_IDs of evidence IEA and ND are not included)  
## got1-- contains GO_IDs of probes) 
got1<- list()  









## gotl1-- contains Ontology information  
gotl1<-rep(0,number) 
for(i in 1:number){ 
pb<-ids1[i] 
gotl1[[i]]<-sapply(got[[pb]], function(x) x$Ontology) 
} 
## get GO terms for GO_IDs 
got2<-list() 
for(i in 1:number){ 
got2[[i]]<-mget(got1[[i]],GOTERM,ifnotfound=NA) 
} 
### Code to get the terms from Goterms object got2 
for(i in 1:number){ 
if(length(names(got2[[i]]))==1){ 













## Code to filter out probes with no mapped goterms and no mapped refseq ids.. 
- 
fit4<-fit3$genes*,”goterms”+ != “NA” 
fit5<-fit3[fit4,] 





































































ind = apply(Detection(sox9data.quantile)>0.99, 1, all) 














"12.5+-" "12.5++" "13.5+-" "13.5++" 
"1" 0 0 1 0 
"2" 0 0 1 0 
"3" 0 0 1 0 
"4" 0 0 1 0 
"5" 0 0 1 0 
"6" 0 0 1 0 
"7" 0 0 0 1 
"8" 0 0 0 1 
"9" 1 0 0 0 
"10" 1 0 0 0 
"11" 0 1 0 0 
"12" 0 1 0 0 
"13" 1 0 0 0 
"14" 1 0 0 0 
"15" 0 0 0 1 
"16" 0 0 0 1 
"17" 0 1 0 0 
"18" 0 1 0 0 
"19" 1 0 0 0 




"V1" "V2" "V3" 
"1" 0 -1 1 
"2" -1 0 -1 
"3" 0 1 -1 
"4" 1 0 1 
 
## V1 (coef1) =13.5++-12.5++ 
## V2 (coef2) =13.5+--12.5+- 
## V3 (coef3) = (13.5++-13.5+-)-(12.5++-12.5+-) 








#### Code for getting GO information done using getOntology,etc from annotate package: 
got<-sapply(go,dropECode,c(“IEA”,”ND”)) 
gotl<-rep(0,number) 




## gotl contains all the information GO_ID , Ontology, Evidence for each of the probe ids. 
## Code to get GO_IDs of probes (GO_IDs of evidence IEA and ND are not included)  
## got1-- contains GO_IDs of probes) 
got1<- list()  








## gotl1-- contains Ontology information  
gotl1<-rep(0,number) 
for(i in 1:number){ 
pb<-ids1[i] 
gotl1[[i]]<-sapply(got[[pb]], function(x) x$Ontology) 
} 
## get GO terms for GO_IDs 
got2<-list() 
for(i in 1:number){ 
got2[[i]]<-mget(got1[[i]],GOTERM,ifnotfound=NA) 
} 
### Code to get the terms from Goterms object got2 
for(i in 1:number){ 
if(length(names(got2[[i]]))==1){ 













## Code to filter out probes with no mapped Refseq ids and GO terms 
secfit4<-secfit3$genes*,”goterms”+ != “NA” 
secfit5<-secfit3[secfit4,] 
















































## Top 200 differentially expressed genes in E13.5 Sox9 +/+ vs Sox9 -/-  contrast
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
1 Tmed2 4.241338 7.01E-19 50 Dctn3 1.605153 1.76E-12
2 Tcp1 4.002704 7.01E-19 51 Pcgf6 1.387469 2.01E-12
3 Col9a1 4.617522 2.08E-18 52 C1qbp 1.728896 2.38E-12
4 Mia1 4.143913 3.20E-16 53 Srebf2 -1.568529 2.49E-12
5 Eif5a 3.151311 3.20E-16 54 Kank1 2.948262 2.52E-12
6 Ppp1ca 2.979874 4.85E-16 55 Bptf -1.965578 2.55E-12
7 Cyp51 2.38009 2.64E-15 56 Msn -1.681963 2.63E-12
8 Ndn 2.521899 2.64E-15 57 Wif1 1.931542 3.74E-12
9 Sumo3 3.314993 3.23E-15 58 Psma1 2.937839 3.74E-12
10 Arf5 2.071115 3.58E-15 59 Nt5dc3 1.26769 3.74E-12
11 Ppm1a 2.559922 3.58E-15 60 Mkks 1.808031 3.74E-12
12 Adk 1.993403 3.75E-15 61 Gde1 1.867244 3.78E-12
13 Ap1s1 2.24676 5.94E-15 62 Papss2 1.861484 3.78E-12
14 Tpm3 2.640824 9.24E-15 63 Capn2 2.406527 4.39E-12
15 "Sep15" 3.240962 1.04E-14 64 Acad9 1.596096 4.71E-12
16 Mtch2 3.145866 1.04E-14 65 Arpc1a 1.933587 5.03E-12
17 Gnas 2.924672 1.26E-14 66 Ddah1 1.649225 5.03E-12
18 Naca 2.618577 2.05E-14 67 Khdrbs1 1.473553 5.08E-12
19 Khdrbs1 2.248854 2.05E-14 68 Vamp3 1.46758 5.49E-12
20 Lass2 3.091408 2.05E-14 69 Ift20 1.688556 5.58E-12
21 Tubb5 3.440765 2.05E-14 70 Eif2b1 1.520166 5.97E-12
22 Psmd13 3.413858 2.43E-14 71 Man2b1 -1.777275 7.12E-12
23 Gnb1 1.886223 4.41E-14 72 Mlx -1.510332 7.74E-12
24 Gorasp2 2.058745 5.47E-14 73 Ufsp2 2.496422 8.00E-12
25 Slc30a5 1.805007 5.71E-14 74 Ndufs2 1.670949 8.47E-12
26 Metap2 2.564438 7.41E-14 75 Ctgf 2.335035 1.08E-11
27 Tmpo 2.480804 8.25E-14 76 Cct3 2.028705 1.40E-11
28 Pdcd5 1.558411 1.34E-13 77 Enah 1.300932 1.47E-11
29 Atp5j 2.147474 1.36E-13 78 Idh1 2.387241 1.51E-11
30 Cdc37l1 1.679175 1.54E-13 79 Ezh2 1.922876 1.51E-11
31 Idh3g 2.089638 1.81E-13 80 Wnt5a 2.470766 1.52E-11
32 Capzb 1.542553 2.33E-13 81 Fam92a 1.785159 1.85E-11
33 St3gal6 1.724836 3.33E-13 82 Ndufv2 -1.847623 1.86E-11
34 Prdx3 1.818977 3.57E-13 83 Imp4 1.594347 1.99E-11
35 Snrpn 2.755274 3.69E-13 84 Hmgcl 1.930183 2.24E-11
36 Crtap 1.960852 4.44E-13 85 Lum 1.781044 2.30E-11
37 Chmp2a 1.508322 4.82E-13 86 Cd9 2.038423 2.33E-11
38 Ndufs3 2.046745 5.92E-13 87 Birc5 1.897692 2.42E-11
39 Slc30a5 1.731864 6.40E-13 88 Ubtf -1.670929 2.43E-11
40 Ube2v1 2.054984 7.43E-13 89 Sfrs5 3.454723 2.71E-11
41 Capn2 2.61876 7.43E-13 90 Acadm 1.638156 2.84E-11
42 Yeats4 1.994184 7.43E-13 91 Srpk2 1.377605 2.92E-11
43 Galnt1 2.021448 7.81E-13 92 Chd3 -1.705049 3.09E-11
44 Scp2 1.55381 8.86E-13 93 Emd 2.358765 3.13E-11
45 Snap23 1.972465 1.16E-12 94 Nt5c -1.367834 3.25E-11
46 Cdh3 -1.736822 1.20E-12 95 Gpr125 1.245461 3.67E-11
47 Hsp90ab1 2.434812 1.30E-12 96 Pmp22 1.307006 3.95E-11
48 Col2a1 3.206371 1.39E-12 97 Trnt1 1.605929 4.68E-11
49 Pfn1 1.533761 1.49E-12 98 Atp5f1 1.942311 5.27E-11
S.NO. Symbol logFC adj.P.Val S.NO. Symbol logFC adj.P.Val
99 Nckap1 2.476977 6.32E-11 149 Chic2 1.303861 8.84E-10
100 Ptx3 1.398417 6.42E-11 150 Mocs1 1.411095 9.54E-10
101 Pum2 1.479686 7.65E-11 151 Saps3 -1.347933 9.54E-10
102 Tial1 1.453562 8.48E-11 152 Taf12 1.167899 1.01E-09
103 Vkorc1 1.649801 1.00E-10 153 Ece1 -1.467336 1.01E-09
104 Abcb10 -1.077711 1.01E-10 154 Hoxb4 -1.669574 1.12E-09
105 Lamp2 1.306495 1.05E-10 155 Nudt5 1.384567 1.16E-09
106 Cdc42ep3 1.560997 1.08E-10 156 Fkbp1a 1.036844 1.19E-09
107 Col2a1 2.399027 1.09E-10 157 Hsd17b10 -1.271091 1.33E-09
108 Ndufs2 1.460093 1.15E-10 158 Ard1a 1.623935 1.34E-09
109 Rexo2 1.608267 1.33E-10 159 Mtx1 1.27623 1.35E-09
110 Mtap1s -1.143222 1.37E-10 160 Etfa 1.319218 1.39E-09
111 Polr2a -1.458707 1.48E-10 161 Pcsk6 1.71417 1.50E-09
112 Tcf12 1.217502 1.49E-10 162 Sepx1 -1.091885 1.55E-09
113 Alg5 1.116384 1.70E-10 163 Sypl 1.512494 1.55E-09
114 Papss1 1.422177 2.12E-10 164 Msi2 1.59707 1.55E-09
115 Atp6v1c1 1.148123 2.14E-10 165 Anxa5 1.145358 1.55E-09
116 Cep120 -1.120122 2.39E-10 166 Lpcat1 -1.372405 1.63E-09
117 Dld 1.282037 2.70E-10 167 Galnt1 1.382696 1.78E-09
118 Col9a1 2.475099 2.74E-10 168 Prpf4 1.227214 1.86E-09
119 Dcn 1.897961 2.79E-10 169 Hoxa2 1.103418 1.92E-09
120 Ssbp2 2.010709 2.85E-10 170 Col4a1 -1.548331 1.92E-09
121 Cdc2a 1.469022 2.94E-10 171 Mrpl9 1.244446 1.98E-09
122 Pitpnc1 1.664914 2.94E-10 172 Sox5 1.910865 1.99E-09
123 Sirpa -1.219979 3.09E-10 173 Rnf4 1.575494 2.06E-09
124 1200009F10Rik1.317005 3.09E-10 174 Dedd2 -1.020901 2.13E-09
125 Spcs1 1.542143 3.25E-10 175 Lamp1 -1.098025 2.18E-09
126 Smarca4 -1.405183 3.25E-10 176 Exoc4 1.173287 2.21E-09
127 Cdc27 -2.085313 3.53E-10 177 Hsp90ab1 1.909086 2.28E-09
128 Mical1 -1.275961 3.57E-10 178 Snrpd3 1.301646 2.32E-09
129 Igfbp2 2.19518 3.83E-10 179 Gnb5 1.464854 2.39E-09
130 Ppp1r9b -1.18452 3.99E-10 180 Setd1a -1.2639 2.42E-09
131 Zscan21 1.330077 4.11E-10 181 Azi1 -1.026922 2.54E-09
132 Notch3 -1.494519 4.15E-10 182 Myo9b -1.391012 2.63E-09
133 Tubg1 -1.333465 4.33E-10 183 Smarcc1 1.691991 2.71E-09
134 Pde6d 1.311247 4.43E-10 184 Tmem50a 1.169114 2.74E-09
135 Ard1a 1.489383 4.88E-10 185 Tnip1 -1.252615 2.82E-09
136 Ak2 1.793321 4.88E-10 186 Dctn1 -1.646648 2.88E-09
137 Fn1 2.328171 4.89E-10 187 Sestd1 1.140115 2.88E-09
138 Ehmt1 1.427812 5.78E-10 188 Itch 1.606644 3.05E-09
139 Arpc1a 1.425235 5.81E-10 189 Nudc 1.443855 3.12E-09
140 Sphk2 -1.129924 5.87E-10 190 Homer1 1.441256 3.24E-09
141 Azi2 1.064192 6.27E-10 191 Zfp207 1.330671 3.53E-09
142 Cct6a 1.224691 6.45E-10 192 Mrps7 -1.103291 3.60E-09
143 Oxct1 1.281305 6.54E-10 193 Slc40a1 -2.307554 3.61E-09
144 Mkl1 -1.856631 7.08E-10 194 Cbx3 1.078314 3.61E-09
145 Hnrpdl 2.006504 7.78E-10 195 Zmpste24 1.337515 3.67E-09
146 Suclg1 2.471127 8.06E-10 196 Fndc3b 1.480912 3.99E-09
147 Bdh1 1.155142 8.84E-10 197 Cyld -1.30386 4.11E-09
148 Ndufab1 1.419 8.84E-10 198 Ulk2 1.245412 4.41E-09
Appendix_2.5
## Top 200 genes differentially expressed in E13.5 Sox9 +/-  vs Sox9-/-
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
1 Mia1 5.424145 5.94E-19 50 Cdc42ep3 1.566127 1.30E-11
2 Col9a1 4.903398 5.94E-19 51 Tshz1 -1.565796 2.34E-11
3 Papss2 3.055207 1.81E-16 52 Atp6v0e 1.234266 2.85E-11
4 Tcp1 3.159912 2.29E-16 53 Notch3 -1.738115 2.87E-11
5 Tmed2 3.133405 7.60E-16 54 Prdx3 1.498388 2.87E-11
6 Wif1 2.735023 4.38E-15 55 Scp2 1.328592 3.47E-11
7 Adk 2.011106 5.08E-15 56 Cope 1.64113 3.64E-11
8 Eif5a 2.768106 6.47E-15 57 Tjap1 -1.144518 4.01E-11
9 Col2a1 4.167855 8.24E-15 58 Metap2 1.93435 4.02E-11
10 Pdcd5 1.769335 1.35E-14 59 Cdk10 -1.613346 4.06E-11
11 Ctgf 3.245283 1.64E-14 60 Col9a1 2.754451 4.26E-11
12 Lum 2.525805 2.28E-14 61 Imp4 1.559989 4.60E-11
13 Hoxd4 -2.121223 3.56E-14 62 Meox1 -1.341482 4.81E-11
14 Naca 2.559007 5.30E-14 63 Afg3l1 -1.309745 4.81E-11
15 Ndn 2.192267 5.71E-14 64 Alg5 1.198952 5.53E-11
16 Col2a1 3.489983 6.25E-14 65 H13 -1.788199 5.67E-11
17 "Sep15" 2.923962 1.42E-13 66 Atp6v0a1 -1.588208 5.87E-11
18 Ppp1ca 2.30728 1.42E-13 67 Vkorc1 1.565277 5.87E-11
19 Kank1 3.42385 1.58E-13 68 Ednra -1.298767 6.32E-11
20 Col27a1 3.497086 1.66E-13 69 Surf1 1.416189 6.66E-11
21 Ptx3 1.890525 1.66E-13 70 Pfn1 1.29433 6.82E-11
22 Gorasp2 1.928194 3.25E-13 71 H47 1.266129 6.82E-11
23 Vkorc1 2.19938 3.65E-13 72 Birc5 2.099232 6.92E-11
24 Crtap 1.983266 4.98E-13 73 Suclg1 2.827532 6.92E-11
25 Atp5j 2.045227 5.53E-13 74 Cdh4 -1.556341 6.93E-11
26 St3gal6 1.694994 6.59E-13 75 Pitpnm1 -1.871127 7.20E-11
27 Arf5 1.638251 6.59E-13 76 Capn2 2.122518 7.24E-11
28 Hoxb4 -2.399043 9.76E-13 77 Eps15l1 -1.371161 7.25E-11
29 Mtch2 2.526849 1.67E-12 78 Psma1 2.570692 7.38E-11
30 Sumo3 2.474949 1.93E-12 79 Cyp51 1.45005 7.70E-11
31 Birc5 2.19103 1.93E-12 80 C1qbp 1.470519 8.16E-11
32 Cd9 2.330708 2.27E-12 81 Sra1 1.600617 8.16E-11
33 Eif2b1 1.623758 2.44E-12 82 Tubb5 2.33714 8.84E-11
34 Nrp1 -2.608874 2.50E-12 83 Spcs1 1.659232 8.84E-11
35 Bcl11a -1.775365 2.64E-12 84 Kcnk1 1.509203 1.01E-10
36 Nrp1 -2.5105 2.68E-12 85 Capn2 2.078295 1.15E-10
37 Gfpt2 1.562756 3.09E-12 86 Anxa5 1.319016 1.15E-10
38 Hprt1 2.086724 3.09E-12 87 Abca3 -1.26916 1.24E-10
39 Afg3l1 -1.262607 3.25E-12 88 Mylc2b 1.922457 1.24E-10
40 Cdc42ep3 1.869492 3.53E-12 89 Slc30a5 1.260851 1.25E-10
41 Idh3g 1.837681 3.58E-12 90 Ift20 1.465939 1.32E-10
42 Papss1 1.746861 3.95E-12 91 Psmd13 2.288841 1.33E-10
43 Pik3r3 -1.532359 4.29E-12 92 Crabp1 -2.125961 1.35E-10
44 Cdh3 -1.632028 5.96E-12 93 Pcsk6 1.949263 1.35E-10
45 Rexo2 1.893211 6.12E-12 94 Ard1a 1.597918 1.37E-10
46 Ndufs3 1.85123 6.12E-12 95 Pmp22 1.2376 1.47E-10
47 Ngfr -2.56792 8.66E-12 96 Srebf2 -1.291133 1.58E-10
48 Gnas 2.162654 1.01E-11 97 Pole3 1.409939 2.11E-10
49 Cxcl12 -1.579391 1.14E-11 98 Jdp2 1.614298 2.34E-10
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
99 Gsk3b -1.966901 2.39E-10 149 Cacna1h -1.016071 2.07E-09
100 Sec61b 1.535901 2.43E-10 150 Cask -1.019275 2.08E-09
101 Mcf2l -2.183255 2.46E-10 151 Ank3 -1.695031 2.18E-09
102 Cct3 1.776626 2.49E-10 152 Smap1 1.166871 2.19E-09
103 Acadm 1.484362 2.56E-10 153 Socs2 -1.293691 2.19E-09
104 Yeats4 1.513031 2.56E-10 154 Sfxn3 -1.013645 2.31E-09
105 Col27a1 1.830883 2.88E-10 155 Polr1d 1.626082 2.31E-09
106 Atp5f1 1.799237 2.95E-10 156 Fes -1.540993 2.43E-09
107 Msi2 1.747744 3.02E-10 157 Slc40a1 -2.36745 2.52E-09
108 Nde1 1.232335 3.03E-10 158 H13 1.932975 2.65E-09
109 Mbnl1 1.311309 3.12E-10 159 Ets2 1.220769 3.21E-09
110 Fndc3b 1.696896 3.28E-10 160 Snap23 1.33709 3.39E-09
111 Ccnd1 1.65017 3.28E-10 161 Gfpt2 1.497326 3.45E-09
112 Rpa2 1.930421 3.44E-10 162 Vamp3 1.074562 3.45E-09
113 Ufsp2 2.090339 3.62E-10 163 Grn -1.081627 3.51E-09
114 Smarcc1 1.886588 3.71E-10 164 Ebf2 -1.486874 3.55E-09
115 Eef1b2 1.978412 3.71E-10 165 Dmpk -1.198531 3.77E-09
116 Mkks 1.450722 3.88E-10 166 Use1 1.223876 3.82E-09
117 Ndufab1 1.481879 4.15E-10 167 Cdc2a 1.285915 4.29E-09
118 Ssbp3 -1.257268 4.15E-10 168 Ard1a 1.530316 4.65E-09
119 Cast 1.238373 4.53E-10 169 Acvr2b -1.391578 4.65E-09
120 Lass2 1.923137 4.70E-10 170 Brp44 1.251051 5.16E-09
121 Sox11 -2.071933 4.80E-10 171 Bptf -1.35312 5.36E-09
122 Chmp2a 1.081894 4.80E-10 172 Pdia5 1.276284 5.39E-09
123 Csnk1e -1.129923 5.69E-10 173 Kirrel3 -1.52567 5.47E-09
124 Col4a1 -1.654446 5.83E-10 174 Pax1 -1.883556 5.47E-09
125 Cald1 1.729252 5.83E-10 175 Pbx2 -1.051726 5.57E-09
126 Slc30a5 1.246233 5.85E-10 176 Ndfip1 1.050274 6.20E-09
127 1200009F10Rik1.276671 6.14E-10 177 Sox4 -1.582093 7.03E-09
128 Ndufs2 1.360853 6.44E-10 178 Reck 1.201002 7.21E-09
129 Arap3 -1.815477 7.91E-10 179 Zfpm2 1.392049 7.25E-09
130 Flnb 2.149975 8.78E-10 180 Arid2 -1.102006 7.34E-09
131 Dctn3 1.19025 8.78E-10 181 Dock9 -1.068823 7.34E-09
132 Bdh1 1.158645 9.18E-10 182 Trove2 -1.079974 7.47E-09
133 Gnb1 1.163101 1.10E-09 183 Rpl29 2.087351 7.63E-09
134 Tpm3 1.504897 1.10E-09 184 Adamts7 -1.283176 7.64E-09
135 Swap70 1.387222 1.16E-09 185 Ing2 -1.108535 7.64E-09
136 Hmgcl 1.583595 1.42E-09 186 Man2b1 -1.117929 7.67E-09
137 Arpc1a 1.476369 1.43E-09 187 App 1.2044 7.96E-09
138 Zfhx3 -2.302004 1.44E-09 188 Hdac11 -1.172851 8.01E-09
139 Mtap1s -1.019328 1.52E-09 189 Cacna1g -1.16348 8.27E-09
140 Taf12 1.150371 1.52E-09 190 Fam92a 1.318051 8.36E-09
141 Trnt1 1.359973 1.52E-09 191 Ggcx 1.737855 8.41E-09
142 Banf1 1.31391 1.52E-09 192 Git1 -1.042181 8.88E-09
143 Sox5 1.94589 1.59E-09 193 Etfa 1.199098 9.20E-09
144 Synpo 1.377022 1.65E-09 194 Ddah1 1.133792 1.02E-08
145 Ap1s1 1.229312 1.65E-09 195 Lipa -2.403987 1.02E-08
146 Klf4 1.480462 1.98E-09 196 Gstp1 1.329597 1.07E-08
147 Nckap1 2.095256 2.05E-09 197 Homer3 -1.540947 1.07E-08
148 Sema3f -1.171863 2.06E-09 198 Mll1 -1.495294 1.12E-08
199 Grlf1 -1.256559 1.14E-08
Appendix_2.6
## Top 200 differentially expressed genes in E13.5 Sox9+/+ vs Sox9 +/-
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
1 Cbx3 1.737928 4.03E-13 50 Bgn -1.187219 1.38E-08
2 Tbrg1 -1.6091 7.29E-13 51 Man2b1 -1.1546 1.53E-08
3 Lamp2 1.577324 2.18E-12 52 Gkap1 1.117323 1.57E-08
4 Hoxd4 1.681983 2.64E-12 53 Nrp1 1.568761 1.68E-08
5 Mcm7 1.897362 3.46E-12 54 Sec31a -1.388874 2.13E-08
6 Khdrbs1 1.728486 3.46E-12 55 Ap1s1 1.017447 2.13E-08
7 Ezh2 2.010168 3.46E-12 56 Slitrk5 1.423649 2.18E-08
8 Ndufv2 -1.773654 3.35E-11 57 Gnao1 1.967042 2.35E-08
9 Dctpp1 -1.192255 1.33E-10 58 Rasa1 1.228538 2.66E-08
10 Nlgn2 1.033141 1.81E-10 59 Atp5e -1.407033 2.69E-08
11 Ppm1a 1.489224 2.06E-10 60 Col27a1 -1.792921 2.69E-08
12 Tgs1 2.058213 2.06E-10 61 Ehmt1 1.102847 2.69E-08
13 Cdc37l1 1.165118 2.06E-10 62 Gigyf1 1.041197 3.44E-08
14 Man1b1 1.353335 2.92E-10 63 Tacc2 1.120904 3.92E-08
15 Selm -1.578625 7.67E-10 64 Ogt 1.035548 4.88E-08
16 Kras 1.113452 8.28E-10 65 H2afy 1.118006 5.52E-08
17 Cxcl12 1.229393 9.42E-10 66 Gnas 2.107167 5.66E-08
18 Pitpnc1 1.533634 9.87E-10 67 Socs2 1.023223 5.82E-08
19 Pdgfc -1.032499 9.87E-10 68 Cd3eap -1.268193 6.64E-08
20 Ppia -1.357874 1.01E-09 69 Tpm3 1.135927 7.07E-08
21 Ttyh1 2.459424 1.01E-09 70 Tpp1 -1.026788 7.50E-08
22 Sepx1 -1.06366 1.57E-09 71 Sf1 -1.095368 8.28E-08
23 Ebf3 1.543658 1.86E-09 72 Klf7 1.286717 8.58E-08
24 Col27a1 -1.603342 1.92E-09 73 Ptpre -1.096925 9.48E-08
25 Csnk1e 1.019637 2.15E-09 74 Mid1ip1 1.332093 9.57E-08
26 Anxa4 -1.183164 2.33E-09 75 Srebf2 1.182881 9.92E-08
27 Hdgf -1.080374 2.79E-09 76 Tmpo 1.161348 1.05E-07
28 Hspa5 -1.321116 2.80E-09 77 Igfbp2 1.537753 1.06E-07
29 Nrp1 1.665535 4.11E-09 78 Slc25a27 1.226574 1.11E-07
30 Mpv17 1.069604 5.63E-09 79 Impa1 -1.419573 1.20E-07
31 Ncstn 1.120875 5.63E-09 80 Taf6 -1.205672 1.24E-07
32 1200009F10Rik-1.228646 5.63E-09 81 Dtx3 1.010803 1.36E-07
33 Rbm39 1.220333 6.34E-09 82 Rtn3 1.061328 1.45E-07
34 Chd7 1.277054 8.28E-09 83 Dcn 1.276006 1.59E-07
35 Plxna2 1.311825 8.28E-09 84 Ptrf -1.640377 1.72E-07
36 Stard4 1.426463 8.48E-09 85 Tmed2 1.107933 1.97E-07
37 Eps15l1 1.02727 8.53E-09 86 Tcof1 -1.078893 2.01E-07
38 Sox11 1.707444 9.28E-09 87 Wnt5a 1.41225 2.31E-07
39 Tshz1 1.091145 9.85E-09 88 Akap9 1.345568 2.68E-07
40 Mrpl36 -1.115091 1.05E-08 89 Sep-15 -1.356888 2.72E-07
41 Exoc4 1.039068 1.08E-08 90 Sharpin -1.054183 2.72E-07
42 Lpcat1 -1.189059 1.14E-08 91 Slit2 1.004058 2.75E-07
43 Papss2 -1.193723 1.20E-08 92 Zfp318 1.111256 2.84E-07
44 Atp6v0a1 1.141886 1.20E-08 93 Cd1d1 1.572631 3.07E-07
45 Kif3a 1.103898 1.26E-08 94 Picalm -1.159732 3.64E-07
46 Acvr2b 1.254632 1.28E-08 95 Stxbp4 1.039499 4.02E-07
47 Traf7 -1.138693 1.28E-08 96 Pias4 1.107013 4.18E-07
48 Penk1 -1.411423 1.29E-08 97 Msx1 1.392231 4.39E-07
49 Mybbp1a -1.205215 1.29E-08 98 Tcf4 1.085242 5.19E-07
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
99 Zfhx3 1.549121 5.50E-07 149 Wnt9a 1.010617 1.47E-05
100 Ednrb 1.635042 6.54E-07 150 Zic3 1.375617 1.69E-05
101 Dlx2 1.783002 6.89E-07 151 Mllt3 1.078848 1.69E-05
102 G3bp2 1.018923 7.10E-07 152 Nrn1 1.501398 1.73E-05
103 Elf2 -1.006493 7.21E-07 153 Tcfap2b 1.865127 1.74E-05
104 Pbrm1 1.095248 7.60E-07 154 Rprm 1.237538 1.85E-05
105 Phlda2 -1.564452 8.49E-07 155 Fus 1.771712 2.22E-05
106 Ebf2 1.014656 9.19E-07 156 Col2a1 -1.090956 2.29E-05
107 Mia1 -1.280232 9.52E-07 157 Olfm1 1.132129 2.31E-05
108 Cdc27 -1.260857 1.02E-06 158 Sparc -1.218892 2.31E-05
109 Tra2a 1.490423 1.10E-06 159 Vldlr 1.346186 2.39E-05
110 Lass2 1.168271 1.10E-06 160 Ndufb4 -1.015251 2.83E-05
111 Rab8b 1.061083 1.15E-06 161 Bmp4 1.028971 3.13E-05
112 Sult4a1 1.412496 1.27E-06 162 Copb1 -1.021554 3.15E-05
113 Ccnl1 1.500706 1.32E-06 163 Thbd 1.024715 3.47E-05
114 Plat 1.263164 1.43E-06 164 Cdk5r1 2.032811 3.51E-05
115 Idh1 1.19644 1.67E-06 165 Vegfa 1.287408 3.54E-05
116 Ndufb2 -1.039124 1.67E-06 166 Ctnna2 1.326312 3.59E-05
117 Epb4.1l1 -1.042835 1.67E-06 167 Dclk1 1.113245 3.84E-05
118 Ank3 1.072419 1.86E-06 168 Nop58 1.322532 4.03E-05
119 Rcor2 1.575177 1.86E-06 169 Cited2 1.206978 4.22E-05
120 Hmga2 -1.252787 1.93E-06 170 Zbtb20 1.242239 4.40E-05
121 Hey1 1.232315 2.06E-06 171 Astn1 1.199905 4.91E-05
122 Amd1 -1.116214 2.54E-06 172 Hoxb5 1.640967 5.32E-05
123 Cdo1 -1.02373 2.73E-06 173 Kit 1.077669 5.37E-05
124 Atp6v1a 1.006155 2.76E-06 174 Kif5c 1.053165 5.58E-05
125 Heph 1.224604 2.78E-06 175 Rtn1 1.805117 6.36E-05
126 Ngfr 1.172239 3.35E-06 176 Ndufb10 -1.03534 6.40E-05
127 Rarb 1.178824 3.40E-06 177 Cacna2d2 1.077818 7.72E-05
128 Heph 1.179946 3.41E-06 178 Reln 1.469053 7.94E-05
129 Mkl1 -1.065234 3.48E-06 179 Pdcd4 -1.420071 8.89E-05
130 Miat 1.767851 4.58E-06 180 1190002H23Rik1.018438 9.06E-05
131 Mtap1b 2.13667 4.93E-06 181 Ptbp2 1.199406 9.79E-05
132 Emd 1.040119 5.36E-06 182 Gap43 1.367199 0.0001224
133 Mtap1b 1.186259 6.41E-06 183 Slc2a3 1.141243 0.0001232
134 Bach2 1.196829 6.59E-06 184 Rtn1 1.999682 0.0001301
135 Col8a1 1.04738 7.16E-06 185 Rpgrip1 -1.237448 0.0001323
136 Igf1 1.487381 8.11E-06 186 Slc4a7 1.285997 0.0001558
137 Psmd13 1.125017 8.32E-06 187 Cspg4 -1.098501 0.0001748
138 Lmna -1.008445 8.76E-06 188 Chodl 1.090936 0.0001821
139 Col18a1 1.358145 8.76E-06 189 Txnip -1.390383 0.000196
140 Ncam1 1.741448 1.06E-05 190 Vldlr 1.004188 0.0001974
141 Tubb5 1.103624 1.06E-05 191 Phip 1.301797 0.0002371
142 Gpr126 -1.503813 1.08E-05 192 Prpf19 1.044634 0.0002496
143 Nav3 1.058299 1.09E-05 193 Top2a 1.097149 0.0003014
144 Dlx1 1.843846 1.21E-05 194 Scarb1 1.072779 0.0003014
145 Vamp8 -1.029553 1.27E-05 195 Gpr85 1.029354 0.0003052
146 Irs1 -1.236514 1.27E-05 196 Cugbp2 1.156712 0.0003094
147 Mcf2l 1.062135 1.41E-05 197 Tcf12 1.275488 0.0003653
148 Amph 1.105833 1.45E-05 198 Ube2b 1.041682 0.0003855
199 Wwtr1 1.146138 0.0004203
## Appendix_2.7
## List of differentially expressed genes in E13.5 Sox9+/+  vs E12.5 Sox9+/+
S.No. Symbol logFC adj.P.Val
1 Aqp1 1.54 6.64E-07
2 Hoxb2 -1.51 6.64E-07
3 Ltbp3 1.04 1.78E-06
4 Entpd3 1.48 4.58E-06
5 Gstt3 1.05 6.11E-06
6 Nfatc1 1.03 1.01E-05
7 Eln 1.33 1.15E-05
8 Cxxc4 -1.17 2.87E-05
9 Dkk3 1.13 3.50E-05
10 Trpm5 1.52 3.50E-05
11 Acvr2b -1.01 3.95E-05
12 Ube1l 1.18 4.64E-05
13 Mia1 1.37 4.72E-05
14 Hoxb4 -1.22 4.72E-05
15 Adamts2 1.39 5.36E-05
16 Ank3 -1.31 8.18E-05
17 Bcl11b -1.53 8.31E-05
18 Mmp9 1.26 0
19 Mtap1b -1.33 0
20 Kif5c -1.23 0
21 Dcc -2.14 0
22 Cacna2d2 -1.1 0
23 Lmna 1.03 0
24 Bcl11b -1.3 0
25 En1 -1.02 0
26 Dclk1 -1.13 0
27 Chrna4 -1.27 0
28 Hoxc9 -1.08 0
29 Hoxb5 -1.83 0
30 Lin7a -1.45 0
31 Dpysl3 -1.53 0
32 Dcx -1.7 0
33 Ddr1 -1.03 0
34 Gdf5 1.19 0
35 Camk2n1 -1.1 0
36 Zfp462 -1.09 0
37 Htra1 1.19 0
38 Klc1 -1.39 0
39 Spp1 1.22 0
40 Ptbp2 -1.01 0
41 Nrn1 -1.3 0
42 Atp1b1 -1.14 0
43 Atp1b1 -1.12 0
44 Mtap1b -1.74 0
45 Cugbp2 -1.06 0
46 Ncam1 -1.47 0
47 Adamts2 1.13 0
48 Gadd45g -1.17 0
49 Cited2 -1.15 0.01
50 Cdk5r1 -1.54 0.01
51 Rtn1 -1.59 0.01
52 Coro1a -1.02 0.01
53 Atp1b1 -1.05 0.01
54 Gdf5 1.29 0.01
55 Ctnna2 -1.18 0.01
56 C1qtnf3 1.1 0.01
## Appendix_2.8
## List of differentially expressed genes in E13.5 Sox9+/- vs E12.5 Sox9+/-  contrast
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
1 Tbrg1 1.91 4.92E-12 69 Itgb5 1.01 3.73E-07
2 Hoxd4 -2.15 4.92E-12 70 Heph -1.52 3.88E-07
3 Anxa4 1.72 1.03E-10 71 Galnt1 -1.01 3.88E-07
4 Khdrbs1 -1.65 4.82E-10 72 Rasa1 -1.06 3.92E-07
5 Cbx3 -1.52 1.19E-09 73 Atp5e 1.48 4.00E-07
6 Meox1 -1.26 1.19E-09 74 Atp6v0a1 -1.03 4.10E-07
7 Lamp2 -1.24 1.41E-09 75 Hoxb4 -1.2 4.71E-07
8 Aqp1 1.65 1.41E-09 76 Tpm3 -1.14 5.27E-07
9 Ezh2 -1.76 1.48E-09 77 B3gat1 1.58 5.41E-07
10 Bgn 1.47 2.10E-09 78 Enpp2 1 5.65E-07
11 Cxcl12 -1.35 2.10E-09 79 En1 -1.26 6.41E-07
12 Tacc1 -1.04 2.42E-09 80 C1qtnf3 1.95 6.41E-07
13 Mia1 1.97 3.92E-09 81 Sep-15 1.37 6.45E-07
14 Ndufv2 1.47 4.90E-09 82 Traf7 1.1 6.54E-07
15 Mcm7 -1.66 5.19E-09 83 Nrp1 -1.21 7.71E-07
16 Lmna 1.82 5.29E-09 84 Pias4 -1.1 8.61E-07
17 Selm 1.68 5.63E-09 85 Cyr61 1.2 8.66E-07
18 Tshz1 -1.24 5.78E-09 86 Klf4 1.16 1.27E-06
19 Entpd3 1.58 8.69E-09 87 Pax1 -1.17 1.38E-06
20 Slc14a1 -1.48 1.00E-08 88 Pcdh7 -1.06 1.39E-06
21 Tmem45a 1.19 1.03E-08 89 Col1a1 1.27 1.53E-06
22 H2afy -1.43 1.29E-08 90 Hoxb5 -2.16 2.22E-06
23 Gstt3 1.12 1.29E-08 91 Impa1 1.24 2.39E-06
24 Ppm1a -1.11 1.31E-08 92 Col27a1 1.27 2.61E-06
25 Ehmt1 -1.49 1.31E-08 93 Nrp1 -1.08 3.15E-06
26 Ptpre 1.4 1.67E-08 94 Lmna 1.31 3.22E-06
27 Wif1 1.25 1.67E-08 95 Pbrm1 -1.11 3.22E-06
28 Bcl11a -1.01 1.73E-08 96 Pik3r3 -1.11 3.42E-06
29 Dctpp1 1.17 2.08E-08 97 Ebf3 -1.09 3.52E-06
30 Zfhx3 -1.64 2.27E-08 98 Zfhx3 -1.63 4.73E-06
31 Gna13 -1.07 2.27E-08 99 Pja2 -1.06 4.85E-06
32 Zfp318 -1 2.96E-08 100 Herc2 -1.11 4.90E-06
33 Man1b1 -1.29 3.16E-08 101 Prom1 -1.02 5.27E-06
34 Ppia 1.15 3.39E-08 102 Rpl12 1.06 5.78E-06
35 Tgs1 -1.88 3.39E-08 103 Ebf1 -1.01 6.11E-06
36 Stard4 -1.22 3.77E-08 104 Gnb2l1 1.26 6.39E-06
37 Klf7 -1.37 3.95E-08 105 Alcam -1.09 6.86E-06
38 Trnau1ap 1.09 4.16E-08 106 Shox2 -1.62 6.99E-06
39 Ebf1 -1.04 4.33E-08 107 Ptrf 1.47 8.53E-06
40 Pitpnc1 -1.2 4.33E-08 108 Prkx -1.07 8.67E-06
41 Tmpo -1.05 4.33E-08 109 Bach2 -1.37 9.58E-06
42 Mpv17 -1.12 4.33E-08 110 Vamp8 1.18 9.85E-06
43 1200009F10Rik 1.29 4.64E-08 111 Adamts2 1.08 9.88E-06
44 Hspa5 1.29 4.64E-08 112 Pdcd4 1.72 1.17E-05
45 Sharpin 1.34 4.64E-08 113 Cd9 1.03 1.48E-05
46 Gpc3 -1.12 5.04E-08 114 Ndufb4 1.23 1.49E-05
47 Mmp9 1.62 5.61E-08 115 Rprm -1.02 1.67E-05
48 Acvr2b -1.13 6.05E-08 116 Cd200 1 1.96E-05
49 Heph -1.4 6.80E-08 117 Dcc -1.81 2.18E-05
50 Phlda2 1.81 9.53E-08 118 Ccnt2 -1.06 2.38E-05
51 Cdo1 1.31 9.53E-08 119 Clint1 1 2.91E-05
52 Lum 1.05 1.04E-07 120 Ptbp2 -1.06 3.35E-05
53 Eps15l1 -1.04 1.39E-07 121 Col18a1 -1.49 3.84E-05
54 Lass2 -1.01 1.43E-07 122 Cited2 -1.34 4.44E-05
55 Ncstn -1.09 1.62E-07 123 Adamts2 1.21 4.60E-05
56 Col27a1 1.65 1.62E-07 124 Cd1d1 -1.11 0
57 Exoc4 -1.13 1.64E-07 125 Hoxd12 -1.04 0
58 Sepx1 1.03 1.73E-07 126 Cox7b 1.09 0
59 Slitrk5 -1.51 2.28E-07 127 Gnas -1.36 0
60 Tbx5 -1.14 2.38E-07 128 Usmg5 1.06 0
61 Stxbp4 -1.05 2.38E-07 129 H13 -1.07 0
62 Caln1 1.16 2.38E-07 130 Wapal -1.12 0
63 Fez2 -1.05 2.56E-07 131 Lipa -1.1 0
64 Eln 1.17 2.93E-07 132 Dync2h1 -1.01 0
65 Ube2j1 1.24 3.05E-07 133 Cdk5r1 -1.27 0
66 Ccnd1 1.02 3.05E-07 134 Zic3 -1.02 0
67 Ebf2 -1.28 3.31E-07 135 Mtap1b -1.15 0
68 Hoxc6 -1.18 3.62E-07 136 Cav1 1.03 0
## Appendix_2.9
## List of differentially expressed genes in (E 13.5 Sox9 +/+ - E13.5 Sox9 +/-)-(E12.5 Sox9+/+ -E12.5 Sox9 +/-)
S.No. Symbol logFC adj.P.Val S.No. Symbol logFC adj.P.Val
1 Lamp2 1.72 1.25E-07 66 Mbd4 1.17 0
2 Wipi1 1.27 3.89E-06 67 Ogt 1.15 0
3 Cbx3 1.59 3.89E-06 68 Vegfa 1.22 0
4 Tbrg1 -1.41 3.89E-06 69 Ptpre -1.09 0
5 Slc14a1 1.77 4.65E-06 70 Traf7 -1.14 0
6 Ndufv2 -1.64 4.65E-06 71 Bdp1 -1.17 0
7 Hoxd4 1.52 4.65E-06 72 Camk2n1 -1.58 0
8 Psmc2 -1.08 4.65E-06 73 Impa1 -1.39 0
9 Lass2 1.45 5.59E-06 74 Slc27a1 1.06 0
10 Cxcl12 1.35 8.85E-06 75 Sharpin -1.09 0
11 Tbx5 1.63 1.01E-05 76 Tcof1 -1.05 0
12 Ppm1a 1.26 1.03E-05 77 Mdh2 -1.06 0
13 Meox1 1.14 1.22E-05 78 Wnt5a 1.38 0
14 Ppia -1.36 1.27E-05 79 Nav1 -1.23 0
15 Tacc1 1 1.27E-05 80 Acsl4 -1.38 0
16 Anxa4 -1.3 1.29E-05 81 Sep-15 -1.34 0
17 Mcm7 1.64 1.53E-05 82 Stmn1 -1.41 0
18 Khdrbs1 1.34 1.53E-05 83 Smarca5 -1.39 0
19 Dock9 1.1 1.53E-05 84 Fig4 -1.46 0
20 Foxp4 1.05 1.53E-05 85 Elf2 -1.06 0
21 Ednra 1.1 2.14E-05 86 Top1 -1.21 0
22 Gpc3 1.3 2.14E-05 87 Dynll2 -1.09 0
23 Trnau1ap -1.22 2.14E-05 88 Prss12 1.01 0
24 Adcy4 1.25 3.43E-05 89 Atp5e -1.35 0
25 Nfatc1 1.13 3.43E-05 90 Txnrd1 -1.35 0
26 Ezh2 1.46 3.57E-05 91 Selm -1.09 0
27 Igfbp4 1.03 4.14E-05 92 Crip2 -2.03 0
28 Chrd 1.07 4.45E-05 93 Mpv17 1.02 0
29 Clasp1 -1.3 4.90E-05 94 Pdcd4 -2.02 0
30 Heph 1.51 5.05E-05 95 Cd24a -1.18 0
31 Dctpp1 -1.15 5.05E-05 96 Cdc27 -1.31 0
32 Man1b1 1.29 5.63E-05 97 Hsp90aa1 -1.56 0
33 Tgfb2 1.16 5.88E-05 98 Pax1 1.12 0
34 Afap1 -1.17 7.41E-05 99 Tra2a 1.61 0
35 Gna13 1.02 7.58E-05 100 Snai3 -1.06 0
36 Wfikkn2 1.08 7.82E-05 101 Clint1 -1.19 0
37 Bptf -1.07 8.66E-05 102 Nrn1 -1.64 0
38 Ube2j1 -1.42 9.41E-05 103 Gnas 1.92 0
39 Hspa5 -1.29 9.57E-05 104 Zfhx3 1.04 0
40 Coro1c -1.06 9.77E-05 105 Hnrnpa2b1 1.08 0
41 Stag3 1.46 9.92E-05 106 Calm2 -1.21 0
42 Galnt1 1.16 9.92E-05 107 Samd8 -1.24 0
43 Cct2 -1.44 0 108 Tnrc6a 1.03 0
44 Mpv17 1.09 0 109 Slitrk5 1.14 0
45 Tmed2 1.32 0 110 Alcam 1.07 0
46 Pgam1 -1.14 0 111 Ube2b 1.41 0
47 Tpm3 1.29 0 112 Atp1b1 -1.32 0
48 B3gat1 -1.8 0 113 Ccnl1 1.48 0
49 Tgs1 1.72 0 114 Cdc26 -1.01 0
50 Top2b -1 0 115 Cldn1 1.06 0.01
51 Sepx1 -1.06 0 116 Bcl11b -1.16 0.01
52 Ehmt1 1.24 0 117 Dync1h1 -1.13 0.01
53 Stard4 1.1 0 118 Sp3 -1.12 0.01
54 Snap23 1.07 0 119 Gnb2l1 -1.13 0.01
55 Heph 1.64 0 120 Bmp4 1.09 0.01
56 Fez2 1.08 0 121 Rraga -1.03 0.01
57 Mapre2 -1.16 0 122 Lpin2 1.01 0.01
58 Atp1b1 -1.9 0 123 Gadd45g -1.38 0.01
59 Pitpnc1 1.07 0 124 Bcl11b -1.15 0.01
60 Pcdh7 1.24 0 125 Sema3a 1.1 0.01
61 Dtx3 1.23 0 126 Cyfip2 -1.23 0.01
62 Cct7 -1.02 0 127 Dclk1 -1 0.01
63 Fxr2 -1.13 0 128 Amd1 -1.07 0.01
64 Taf12 -1.14 0 129 Chodl 1.5 0.01
65 Mrpl36 -1.02 0 130 Tns1 1 0.01
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Extraction of Zebrafish genomic DNA  
PKDB buffer composition: 
 Stock Final 
Tris-HCl 1M (pH-7.5) 50mM 
EDTA 0.5M 5mM 
SDS 10% 1% 
NaCl 5M 0.2M 
Proteinase K 5mg to 50ml 
 
1) An adult fish was put in ice for 5 minutes and then chopped into very small 
bits of tissue. This was put in PKDB and incubated at 37°C overnight. 
2) Following incubation, 0.5ml was aliquoted into eppendorf tubes. 
3) To 0.5ml of the lysate, 0.5ml of phenol/chloroform was added and mixed well 
by inversion. 
4) The mixture was centrifuged for 3mins at maximum speed. 
5) The aqueous phase was transferred to a new tube without disturbing the 
interphase. 
6) To this, 3volumes of 100% ethanol was added and mixed by inversion. 
7) The DNA precipitate was pelleted by centrifugation for 5 minutes at 
maximum speed. 
8) The supernatant was discarded and washed with 70% ethanol. 
9) The pellet was then resuspended in 50µl of H2O. 
